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ABSTRACT 
 
 
 The objective of this research was to investigate antibiotic alternatives to controlling 
Eimeria and necrotic enteritis in chickens. Eimeria are apicomplexan intestinal parasites 
ubiquitous to commercial poultry production. Because of their ubiquitous nature, control of 
coccidia is required in essentially every commercial poultry facility. Coccidia replicate 
intracellularly in the host intestinal epithelium, which not only causes nutrient malabsorption, but 
predisposes the birds for necrotic enteritis. Necrotic enteritis and coccidiosis cost the poultry 
industry a combine US $9 Billion annually.  With consumer preference shifting towards 
antibiotic-free animal production, developing and implementing viable alternatives will continue 
to be crucial to sustainable agriculture. Antibiotic-free poultry production is continuing to grow 
in market share and in order to maintain the low-cost of the world’s most popular protein, viable 
antibtioic alternatives need to be elucidated.  
  My first aim was to evaluate the potential of functional feed ingredients as interventions 
to mitigate necrotic enteritis in broiler chickens experimentally co-infected with Eimeria spp. 
and C. perfringens. Because of their antimicrobial activities, functional feed ingredients, 
including dietary prebiotics and botanical extracts, are widely seen as potential alternatives to 
antibiotics in the prevention and management of gastrointestinal disease in poultry. We 
administered a dietary prebiotic or a botanical extract blend to broilers under experimental co-
infection with Eimeria spp. and C. perfringens and evaluated growth performance, gross 
intestinal lesions, and gastrointestinal counts of C. perfringens. 
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 My second aim was to profile the longitudinal response of commercial broiler operations 
to bioshuttle administration. Referred to as a bioshuttle, ionophores can be administered post-
vaccination to mitigate Eimeria vaccine-related performance losses. Although vaccine 
administration has been demonstrated to restore drug-sensitive Eimeria populations, it is 
unknown whether similar population shifts occur as a result of commercial bioshuttle use. In 
order to address this unmet need we took field data to profile the response of bird performance 
and coccidia presence before, during, and after bioshuttle application using aggregate production 
data (e.g., live weights, adjusted FCR, etc.) over 12-months from a large commercial broiler 
integrator as indicators of anticoccidial drug sensitivity. 
 My last aim was to investigate the potential of Acetyl CoA-Carboxylase (ACC) as a 
novel target for the development of anticoccidial drugs in vivo. Acetyl-CoA Carboxylase 
(ACCase), responsible for conversion of Acetyl-CoA to Malonyl-CoA, is an essential metabolic 
reaction. Because of low conservation in structure between apicomplexans and vertebrates, 
inhibitors of apicomplexan ACCase are predicted to have low toxicity in chickens. We 
administered ACCase inhibitors to broilers chicken experimentally infected with Eimeria spp. 
and evaluated growth performance. From the studies, we determined administration of phenoxy 
carboxylic acid inhibitors of apicomplexan ACCase inhibit coccidia in vivo and mitigated 
coccidiosis in experimentally infected broiler chickens. 
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NOMENCLATURE 
 
 
AUC Area under the curve 
BW Body weight 
BWG Body weight gain 
FC Feed consumption 
FCR Feed consumption ratio  
LS Lesion score  
NE Necrotic enteritis  
OC Oocyst count 
OPG Oocyst per gram feces 
UIC infected un-medicated control 
UUC Uninfected un-medicated control 
WG Weight gain  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
 
 Enteric pathogens, such as Eimeria and C. perfringens-associated necrotic enteritis pose 
significant threats to animals produced for meat. Damage from coccidia replication causes 
reduction in feeding, digestive processes, nutrient absorbption, dehydration and suscpetibility to 
other diseases such as necrotic enteritis (154). Necrotic enteritis (NE), induced by prolieration of 
pathogenic Clostridium perfringens, is also associated with varying levels of intestinal tissue 
damage and reduced acquistion of nutrients (178, 211). Necrotic enteritis and coccidiosis cost the 
poultry industry a combined US $9 Billion annually from preventative costs and performance 
losses (150, 239). Losses from coccidiosis have been reduced with in feed anticoccidials or live 
coccidia vaccines while C. perfringens/NE is primarily controlled by antibiotics. Some products 
such as ionophores, have both anticoccidial and anticlostridial properties, and their inclusion 
reduced coccidiosis and necrotic enteritis (112, 144).  
  In-feed subtherapeutic antibiotics have been used in poultry production for the past 50 
years. The antibiotics helped to improve feed efficiency as well as reduce mortality from 
diseases such as NE (77). When European countries removed antibiotics from poultry 
production, NE incidence increased (117). There has been research conducted on many 
alternatives with variable levels of success (103, 110, 202, 220) for controlling NE.  
 Eimeria are apicomplexan intestinal parasites ubiquitous to commercial poultry 
production. Because of their ubiquitous nature, control of coccidia is required in essentially 
every commercial poultry facility. Coccidia replicate intracellularly in the host intestinal 
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epithelium, which not only causes nutrient malabsorption, but predisposes the birds to 
subsequent diseases such as necrotic enteritis (40). 
 Most commercial poultry production facilities have some amount of Eimeria and with 
large flocks of birds raised in confined housing, these parasites have created a niche that make 
them virtually impossible to eliminate (154).  
 Historically, ionophores were included in broiler diets, serving as an anticoccidial and 
antibiotic (38). As more poultry producers remove antibiotics from production, the use of these 
products is limited. It seems unlikely to find a single product that will replace ionophores, so it is 
important to discover efficient anticoccidials and products which control C. perfringens. This 
review focuses on current and future control of Eimeria and necrotic enteritis.  
Nine species that have been identified to infect the domestic chicken: E. acervulina, E. 
brunetti, E. hagani, E. maxima, E. mitis, E. mivati, E. necatrix, E. praecox, and E. tenella. Seven 
of these species are most commonly associated with clinical coccidiosis in commercial chicken 
production. E. hagani has been considered a doubtful species because of the incomplete original 
description (154). E. mivati has also been debated as a species and was most recently 
demonstrated to be a variation of E. mitis (238).  Eimeria species disseminate throughout the 
intestinal tract and can cause simultaneous infection, representing a disease complex (249). 
Eimeria infect different portions of the intestines, but interspecies competition is observed in 
heavy infections (247, 248).  
Poultry Eimeria do not have intermediate hosts (152) and unlike Apicomplexa parasites 
such as Toxoplasma, they are self-limiting. The life cycle of Eimeria are a series of stages, with a 
specific number of schizont generations depending on species (93). Figure 1.1 shows the life 
cycle of E. tenella. When sporulated oocysts are ingested, the gizzard mechanically ruptures the 
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oocyst wall, releasing sporocysts. Trypsin and bile released in the duodenum promote ex-
cystation of sporozoites. Depending on the species, sporozoites penetrate site-specific host 
mucosal cells in different segments of the intestinal tract. Some sporozoites of Eimeria (E. 
brunetti and E. praecox) develop within the same cells they initially penetrated (218). Other 
species’ sporozoites (E. acervulina, E. maxima, E. necatrix and E. tenella) are transported via the 
crypt epithelium and develop in different sites (129, 134). The sporozoites become trophozoites 
and undergo rapid fission schizogony. This multiplication is asexual, so daughter cells are 
genetically identical. The daughter cells (merozoites), rupture and individually penetrate more 
mucosal cells. The merozoites grow into second and third generation schizonts. Because 
merozoites individually infect cells, each generation causes significant damage to the infected 
intestinal segment. Clinical signs, such as bloody feces during E. tenella or E. necatrix 
infections, are associated with this schizont maturation.  
As merozoites mature, they sexually differentiate into either macrogamonts or 
microgamonts. Microgamonts are the male form and produce microgametes. Microgametes are 
motile and fertilize macrogamonts (female form) by penetrating host cells (218). Upon 
fertilization, a zygote is produced which will mature into an oocyst. Each fertilization results in a 
new oocyst, so infection of a naive host with one oocyst has the potential to generate thousands 
of oocysts to be passed in feces. Eimeria species vary in their reproductive indices, for example 
E. acervulina has a high reproductive potential where E. maxima has a much lower potential 
(252). After maturation, the oocysts are released into the intestinal lumen. The unsporulated 
oocysts are shed in the feces and un-infective until sporulated. Sporulation of the oocyst requires 
adequate access oxygen, a temperature range of 10°C- 30°C, with 30°C being optimal (179). The 
sporulated oocysts are resistant to many disinfectants and can remain infective for up to 602 days 
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in a chicken house (182). Being raised in high-density and coprophagy being a normal behavior 
in chickens, non-motile oocysts are frequently ingested.   
To control coccidiosis, the poultry industry has used three main approaches: 1) 
anticoccidials 2) vaccination 3) improving management practices. Each approach has shown to 
help production, but none seem to be without flaws. Anticoccidial drugs have been used 
extensively as affordable coccidia control (172). Vaccination with live coccidia hasn’t 
historically been used as much as anticoccidials, but with drug resistance concerns and removal 
of ionophores from many production facilities, this alternative has begun to grow in popularity 
(35, 249, 255). While reducing oocysts on a farm would reduce coccidia issues, it has proven to 
be near impossible. The indoor rearing conditions for a modern broiler promoted Eimeria 
proliferation and these parasites are now considered ubiquitous in commercial facilities (34, 
137).  
Sulfanilamide was the first drug used as an anticoccidial to treat chicken coccidiosis in 
1939 (133). A few years later, it was determined that low levels of sulfaquinoxaline could be 
included in chicken diets for prophylaxis of coccidiosis (90). The use of low-dose anticoccidials 
was beneficial for the expansion of intensive poultry and was a catalyst to the rapid growth 
capabilities of the industry. Anticoccidial compounds are affordable (less than $0.01/bird) and 
consistent, which also contributed to their wide-spread use (151). Because of the growth of the 
industry, and the wide-spread use of anticoccidials, it is not surprising, the United States broiler 
industry spends an estimated $127 million annually on anticoccidial drugs (33).  
Anticoccidials can be described as coccidiostats or coccidiocidals. Coccidiostats arrest 
the growth of intracellular life stages and so parasite development will continue after drug 
withdrawal. Coccidiocidals on the other hand, destroy the parasite, preventing continuation of 
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development after drug removal. Some anticoccidials, such as ionophores, have both 
coccidiostatic and coccidiocidal properties.   
There are three main categories of anticoccidial drugs (172):  
1. Synthetic compounds, also known as ‘chemicals’: These drugs have a specific action 
against parasite metabolism (ex: nicarbazin, robenidine).  
2. Ionophores or polyether antibiotics: These antibiotics are produced by the 
fermentation of Streptomyces or Actinomadura spp. They act by rupturing the 
parasite via osmotic balance interference. Ionophores work by creating lipophilic 
complexes that transport ions into the parasite’s cell, offsetting the cross-membrane 
gradient. They affect influx of ions with different charges and so are broken into three 
categories and more details in Table 1.1:  
a. Monovalent Ionophores (monensin, narasin and salinomycin) 
b. Monovalent glycosidic ionophores (maduramicin and semduramicin) 
c. Divalent Ionophores (lasalocid)    
3. Mixed products: combination of chemical and ionophore or two chemicals 
(nicarbazin/narasin, meticlorpindol/methylbenzoquate respectively.   
 
 A factor that has allowed the ionophores to continuously be effective is “leakage”, where 
the drugs work on the majority of parasites infecting birds, but a few bypass the drug, and allow 
the bird to develop natural immunity (91). Another benefit of some ionophores is gram-positive 
antibacterial activity against Clostridium perfringens, the causative agent of necrotic enteritis 
(187).  However, this characteristic has resulted in them being classified as antibiotics, and their 
future use is in question as more poultry producers grow more chickens without any antibiotics.  
  6 
Varying amounts of reduced sensitivity and resistance have been observed for all 
commeriaclly available anticoccidial drugs (19, 30, 153, 174). Most anticoccidials don’t prevent 
development of immunity, which could explain the continued success of these drugs (120). 
Producers also rotate drugs throughout a grow-out (shuttle) and rotate between flocks (rotation), 
which help to reduce the resistance pressure.  
  Antiparasitical and Anticoccidial drug discovery budgets have drastically been reduced 
in major pharmaceutical companies (79). Some research universities have filled this gap and 
placed emphasis on drug discovery with new molecular techniques. However, there have only 
been 2 new anticoccidial drugs introduced in the past 20 years.    
 Several compounds have been described and tested in vitro or in vivo, with varying levels 
of success (135, 196, 203, 207, 245).  The World Association for the Advancement of Veterinary 
Parasitology outlined guidelines for evaluating anticoccidial efficacy (105). These guidelines 
were aimed to set international standards for evaluating anticoccidials. Research testing novel 
anticoccidials should use this guideline for experimental design and for evaluating already 
published data.  
 With consumer preference shifting, inclusion of anticoccidial compounds may be more 
restricted in the future. Because ionophores are antibiotics, their use has been reduced as more 
poultry producers move to antibiotic-free production. Chemical anticoccidials are being used 
more frequently in antibiotic-free production, so resistance may become even more of an issue.  
 Plentiful drug alternatives have been investigated for anticoccidial properties. Varying 
results have led to confusion and no clear “silver bullet”. However, with consumers demanding 
poultry raised without antibiotics, producers have been forced to find viable alternatives. Some 
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of these ingredients such as probiotics, essential oils and organic acids, have been tested for 
anticoccidial properties and are described below.  
 Probiotics, which are live strains of bacteria, have become more popular as chicken 
producers move away from antibiotic-use (101). Most of the research done with probiotics has 
focused on the efficacy of the bacteria to exclude the bad or pathogenic bacteria, but some of the 
research done with Eimeria and probiotics has shown promising results. It has known for many 
years that Eimeria and host bacteria have an interaction, whether through the increase severity of 
coccidial infections in conventional chickens when compared with gnotobiotic chickens, or as a 
predisposing factor of necrotic enteritis (40, 72, 188, 189). Some research has shown pro- and 
prebiotics alleviate the negative impact Eimeria infections has on body weights (23, 65). Results 
of selected published research with Eimeria and probiotics are summarized in Table 1.3. The 
exact mechanism of interaction has not been determined and may be different for each probiotic 
and species of Eimeria. There are several proposed mechanisms of the interaction of probiotics 
and Eimeria:  
1. Probiotics produce early immune stimulation, resulting in greater resistance to 
Eimeria infections (59, 60, 215).  
2. Probiotics inhibit Eimeria sporozoite penetration in vitro (100, 219). 
3. Probiotics may reduce severity of lesions, but allow oocyst cycling, promoting 
immunity development (23).    
 Several researchers have investigated a probiotic mix with Enterococcus faecium, 
Bifidobacterium animalis and Lactobacillus salivarius both in water and in feed with varying 
ability to reduce Eimeria lesions, oocyst output and improve performance (7, 84, 185). The 
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varying anticoccidial results with probiotics may limit their use in the field and could potentially 
be more effective with an optimized dosage and delivery system.   
 Essential oils are another alternative that have been marketed to have anticoccidial 
properties. Essential oil products extracted from a variety of plants and have been shown to have 
mixed anticoccidial properties (111). Table 1.2 summarizes some of the research done with 
essential oils and Eimeria challenges. Artemisia, tea tree, thyme and have been demonstrated to 
have oocysticidal activity (184). The oocyst spends very little time in the chicken though, so this 
application may have more efficacy if used as a disinfectant.  The hydrophobic properties of the 
essential oils are thought to disrupt the oocyst walls (111).  
 Aloe vera supplementation resulted in reduction of E. maxima lesion scores and oocyst 
shedding, which the researchers attributed to potential increase in cell-mediated responses (257). 
Artemisia annua has been demonstrated to have anti-parasitical properties against a variety of 
parasites. A. annua was shown to have significant anticoccidial properties when birds were 
challenged with E. tenella, reducing lesion scores and oocyst output (15). It is hypothesized that 
the mechanism of this essential oil is through iron-free radical production that results in oxidative 
stress of the parasite (14). Essential oil from Beta vulguris (sugar beet), has the active ingredient 
betaine, which has been shown to maintain osmotic pressure in cells (4). It has been shown to 
reduce sporozoites penetration and helps promote intestinal structure during an Eimeria 
infection, reducing the damages from parasite replication (166).  Tumeric has been used as an 
anticoccidial-additive in developing countries because of its antioxidative, anti-inflammatory and 
immunomodulatory properties (3). Reduced lesion score and oocyst counts were observed in E. 
maxima infections but not in E. tenella infections (14). The effects of the oil may vary in efficacy 
depending on the location of the parasite infection, so should be screened with other species. 
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Oregano oil, carvacol and thymol, had anticoccidial effects when supplemented in feed to E. 
tenella infected birds (83). Saccharum officinarum is a sugar cane extract that has been shown to 
have protective effects against E. tenella infections through immune-stimulation.   
 Essential oils have gained popularity as more poultry producers move to antibiotic-free 
production. Unlike drugs which had to go through extensive research before they were put onto 
market, essential oils have little to no regulation. Many of the claims have not been consistently 
shown to have true anticoccidial properties, but rather secondary effects when a coccidia vaccine 
was used. Therefore, interpreting this data should be taken with caution.    
 Organic acids have been shown to have anticoccidial properties. The mechanism is 
thought to be disruption of the intracellular parasite’s pH after the acid penetrates the intestinal 
cells (2). Administration of Acetic acid (3%) to E. tenella infected birds, resulted to lesion 
reduction comparable to Amprolium (6). Butyric acid has become much more popular and is 
marketed to reduce necrotic enteritis as well as having anticoccidial-properties. Because free 
butyrate disappears in the upper GI tract, encapsulation has allowed for the acid to be absorbed 
throughout (132). When used alone or with Clopidol, encapsulated in-feed butyric acid was 
shown to significantly decrease E. maxima lesion scores and improve performance parameters 
compared to the infected control (11). However, when challenged with E. acervulina and E. 
tenella, encapsulated butyrate was lower than the controls, but not similar to Salinomycin (217). 
Because butyrate increases the intestinal integrity and increase epithelial cell turnover, it may 
provide more secondary effects than act as a true anticoccidial. 
Currently vaccines are the only practical alternative to anticoccidial drugs for control of 
coccidiosis in commercial poultry (37). Low doses of live coccidia are administered to chicks on 
day of hatch; through which oral ingestion and subsequent immunity is developed through 
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infection. Full immunity is not developed from the initial infection, and so vaccines rely on low-
dose re-infection to provide future protection and minimize intestinal damage (182). Coprophagy 
is common in chickens, so utilizing this behavior promotes ingestion of feces with low levels of 
oocysts when vaccinated which can induce immunity without significant intestinal damage. In 
addition, low-dose re-infections have been shown to generate a stronger, longer lasting immunity 
than single infections (115).  
Eimeria do not show cross protection, and so infection and subsequent immunity to E. 
tenella does not result in protection from any of the other species. The species of Eimeria also 
vary in their immunogenicity. E. maxima is highly immunogenic, where E. acervulina requires 
several infections to develop immunity (115).  Although highly immunogenic, E. maxima has 
been demonstrated to show significant antigenic variability and so lack of cross protection within 
the species has been observed (209). Martin et al (145) showed that five E. maxima isolates from 
across the United States, formed 3 distinct immunological groups that could not confer immune 
protection. Because of this antigenic variation, most commercial coccidia vaccines have multiple 
strains of E. maxima to provide encompassing immunity.  
When vaccination is optimized, birds develop immunity to coccidia and resistance to a 
subsequent challenge. This can be observed by a reduction in macroscopic lesions, a decrease in 
oocyst production and performance of birds (172). The low numbers of oocysts administered to 
vaccinated birds help maintain performance during a grow out, but can make optimum cycling 
for development of immunity difficult (13). “Trickle down” or multiple low-dose exposure of 
vaccines help to maintain immunity. When a vaccine regularly cycles through chickens, the 
immunity developed is stronger and longer lasting than immunity developed from fewer larger 
infections (114, 115).    
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Cycling vaccines with drugs has been shown to reinstate anticoccidial sensitive coccidia 
populations (107, 148). It has been demonstrated in laboratory settings that mixed population of 
sensitive and resistant Eimeria tenella, the sensitive parasites tended to dominate in the absence 
of medication (136). Comparing sensitivity of isolates from facilities with either live vaccine or 
anticoccidial drugs, the former showed significant increases in sensitivity to diclazuril and 
monensin (173).   It would be logical to hypothesize that in the field, drug-sensitive coccidia 
outcompete the drug-resistant ones from a biological standpoint of resource allocation, resulting 
in more sensitive populations (172). Unlike vaccination, changing the drugs has not been shown 
to reintroduce coccidia sensitivity. Therefore, the intermittent use of live vaccines can provide a 
unique benefit by reintroducing drug sensitive coccidia to poultry houses.  
 Necrotic enteritis (NE) is one of the costliest diseases to the commercial broiler industry, 
estimated to cost producers worldwide US $6 billion annually (239). The etiological agent 
associated with necrotic enteritis is Clostridium perfringens. This bacterium is also associated 
with other diseases in poultry, such as gizzard erosions and gangrenous dermatitis (235).  
Infection with C. perfringens alone will not induce necrotic enteritis, but rather is described as a 
multifactorial disease. In addition to the commonly associated coccidial infection and diet 
components, management also plays a role in the disease onset. Successful induction of the 
disease requires sloughing of intestinal epithelium resulting from intestinal damage, and 
subsequent leakage of protein into the intestinal lumen, setting up for C. perfringens proliferation 
and toxin production (62). Other bacteria, although not more prevalent than the dominant C. 
perfringens, have been isolated from field cases of necrotic enteritis, including Escherichia coli 
and Proteus mirabilis (162). The aforementioned opportunistic bacteria are able to proliferate 
because of the gut epithelium damage caused during a necrotic enteritis episode (167). Counts of 
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C. perfringens have not been found to correlate with disease severity and high numbers have 
been detected in normal birds (162, 170). Although 75%-95% of commercial chickens are 
colonized by C. perfringens, only a small portion of these birds may manifest NE symptoms 
(149). Therefore, NE can be described as dysbiosis because of proliferation of C. perfringens 
out-competing other bacteria. Since C. perfringens is found in normal flora of healthy chickens, 
pre-disposing factors must be present to induce NE disease (256). To support this, researchers 
demonstrated administration of C. perfringens alone did not alter microbial diversity, while 
addition of fishmeal and Eimeria did promote colonization of C. perfringens (214).  
 C. perfringens, a Gram-positive anaerobic spore-forming bacterium, associated with 
necrotic enteritis, most commonly manifested as small intestinal necrosis (158). Over-growth of 
toxin producing C. perfringens is thought to induce NE, but predisposing factors are required to 
promote the C. perfringens proliferation. C. perfringens is one of the fastest growing bacterial-
pathogen, and as a result NE onset is often rapid (205).   
 C. perfringens has been isolated from all stages of poultry production including breeders, 
hatchery, farms, processing and even after chilling  (51, 52, 54, 235). Not all types of C. 
perfringens induce NE, and the disease is associated most commonly with C. perfringens Type A 
and Type C (176). Although most C. perfringens strains isolated from healthy and sick birds are 
type A, it hasn’t been possible to relate a specific subtype with ability to induce necrotic enteritis 
(235). Attempts have been made to induce NE with C. perfringens isolated from healthy birds, 
but no disease was observed, where C. perfringens isolated from birds showing symptoms of 
NE, was able to induce in the disease in naïve laboratory birds (221). Many C. perfringens 
isolates from field outbreaks have been able to induce NE in naïve laboratory chickens, but some 
isolates were avirulent to chickens (28, 47, 210, 224). Extensive research has been conducted to 
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determine what characteristics of a C. perfringens strain allow for NE induction and results from 
this research are highlighted in Table 1.3 with references in favor or against the mentioned 
hypothetical characteristics. Although significant progress has been made in determining the NE 
inducing characteristic, a definite trait unique only to NE producing C. perfringens has yet to be 
elucidated.  
The Bacterial Enteritis Global Impact Assessment (BEGIA) reported in 2010 that NE is a 
global threat to the poultry industry with an 69% prevalence in the United States and Canada 
(233, 234). Molecular characterization of C. perfringens from field cases of NE has shown 
proliferation of only one or two strains (69), where up to five types of C. perfringens have been 
isolated from healthy birds (159).    
 NE disease can be acute clinical or subclinical. Although clinical NE can result in 
mortality of 10-40% of an infected flock, subclinical NE impacts the welfare and performance of 
a far greater number of birds, many of which go untreated (149). Subclinical NE costs producers 
significant losses in feed cost and reduced bird performance (208). Since subclinical NE is 
difficult to diagnose and requires sacrificing random birds from a suspected flock. Confirmation 
of the subclinical form of the disease comes from identifying intestinal or liver lesions (167). 
Lesions from subclinical NE are self-limiting and while the lesions are recovered at five weeks 
post hatch, reduced performance and increased feed conversion can be observed through the 
entire grow-out of the broiler (167). NE lesions can be some of the most severe of any disease in 
the chicken intestine (256).  
Wet litter is associated with subclinical NE, and in some instances it is the symptom 
farmers use to initiate therapeutic medication (251). Wet litter should be noted with caution due 
to the many issues such as feed quality, mycotoxins, ventilation, and infection with viruses, 
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bacteria or coccidia have been associated with the symptom (39).  Due to the differences in 
manifestation of subclinical NE, histological examination is necessary for proper diagnosis (104, 
162).  
NE does not follow Koch’s postulate that a disease-causing organism would not be 
present in a healthy individual, so one must manage predisposing factors of this multifactorial 
disease to reduce incidence (231). Some of these pre-disposing factors include Eimeria infection, 
stress, high dietary protein and wheat or barley-based diets in the presence of pathogenic C. 
perfringens (157, 167, 186). A pathogenic C. perfringens is required to manifest the disease 
(222).   
Coccidia has been known for quite some time to be a common predisposing factor to NE 
(8, 40, 251). Intestinal damage caused by coccidia infection has been shown to predispose birds 
to necrotic enteritis. Infection with coccidia is associated with increased gut stasis, giving rise to 
a nutrient rich environment for possible C. perfringens proliferation (199). Coccidial infections 
have been shown to decrease intestinal pH, which has been shown to decrease proliferation of C. 
perfringens (190, 232).  
C. perfringens is found in the ceca of healthy chickens; however, necrotic enteritis 
lesions are characterized by intestinal C. perfringens. Research with birds co-infected with E. 
necatrix and C. perfringens, showed a significant increase in intestinal C. perfringens (18). It 
therefore seems plausible that Eimeria damage promotes intestinal colonization of the 
opportunistic C. perfringens. It should be noted that C. perfringens was not increased when E. 
tenella was administered to birds (125). This may explain why intestinal species of Eimeria such 
as E. necatrix and E. maxima, are more likely to predispose birds to necrotic enteritis than E. 
tenella.    
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Coccidial infections induce T-cell mediated responses in birds, resulting in increased 
mucogenesis(222). This increased mucogenesis has been shown to promote the proliferation of 
C. perfringens and subsequently the pathogenesis of NE (222). The increase in mucous in the gut 
provides a nutritional substrate for C. perfringens, subsequently favoring proliferation (40). 
Some associate the increase use of live coccidia vaccines to increase of NE. This may be 
explained by the subclinical form of coccidiosis occurring from vaccination is enough intestinal 
damage to promote NE. It may also be explained that in addition to vaccine use increasing, in-
feed antibiotics and anticoccidials are continuously being removed from the poultry production 
cycle. These drugs have been shown to provide relief from NE, and when they aren’t included in 
diets, C. perfringens is able to more readily replicate (144).  
Williams et al. (253) hypothesized that clinical coccidiosis exacerbates NE, where 
subclinical coccidiosis protects from NE. Clinical infections with E. necatrix and C. perfringens 
showed increased edema which was absent in single infections of either pathogen (18). Coccidial 
vaccines have been shown to mitigate the pathogenesis of NE (20, 229, 253). An explanation for 
this observation could be that controlled infection with Eimeria allows for early immunity 
development. This immunity in-turn provides minimal gut damage when the birds are exposed to 
high numbers of C. perfringens at 14-21 days of age, which may in turn minimize the 
manifestation of NE (251). It should be noted that these studies took place in controlled settings 
where application of the vaccine was orally given to respective birds. In field studies, where 
coverage may not be 100%, coccidial vaccines have been observed to predispose to NE (70). 
 It should be noted that although coccidia is commonly associated with NE, clinical 
coccidiosis cases have been reported without necrotic enteritis and vis versa (251). Coccidiosis 
should therefore be viewed as a component to the multifactorial NE.  
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Historically in-feed antibiotics, also known as antibiotic growth promoters (AGP) have 
provided cheap and reliable NE control. When antibiotic growth promoters were used, NE was 
not a common issue for poultry producers (118). However, as more countries remove these 
products from the market, NE incidence has consequentially rose (235). These bans will 
inevitably change the bacterial microflora in commercial poultry intestinal tracts and require 
antibiotic alternatives to control disease (128, 202, 235). Heavy research has been placed on 
antibiotic alternatives and many products have demonstrated variable efficacy (16, 80, 202, 235).   
Gaucher et al (78), conducted a survey comparing performance and bird health between 
drug-free and conventional poultry production facilities, and showed clinical and subclinical 
necrotic enteritis was seen in 27.45% and 49% of the drug-free flocks and none of the 
conventional flocks.  
Inclusion of subtherapeutic levels of some antibiotics has been demonstrated to prevent 
NE (68, 168, 206). Some coccidiostatic drugs, such as ionophores, have been shown to prevent 
C. perfringens-associated necrotic enteritis (253). Their future use remains uncertain as more and 
more producers shift to antibiotic free production.  
Management has been another avenue used to reduce NE incidence (228). Tsiouris et al. 
(230), showed that feed restriction reduced necrotic enteritis lesions in an experimental model 
Since feed restriction improves blood circulation to intestinal mucosa, the researchers concluded 
this circulation may help intestines from becoming necrotic (230).  
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Figure 1.1. Life Cycle of Eimeria, taken from (151) with Permission from Wiley Publishing.  
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Table 1.1 Anticoccidial Chemicals  (modified from (32, 172)) 
Drug Trade 
Name 
Target(s) Mode of Action 
Amprolium Amprol 1st generation 
schizont 
Inhibits thiamin (vitamin B1)  
absorption 
Clopidol Coyden sporozoite Allows parasite penetration into host 
cell but prevents further development- 
coccidiostat effect (242) 
Decoquinate Deccox sporozoite Affect parasite metabolism- blocks 
electron transport in mitochondria 
(193) 
Diclazuril Clinacox multiple stages Unknown 
Halofuginone Stenorol asexual stages Inhibit parasite penetration and further 
development in host cells (126) 
Nicarbazin Nicarb sporozoite Not defined but thought to affect 
parasite’s ability to generate energy, 
directed against developing second-
generation schizonts 
Nitrobenzamides Zoalene asexual stages Thought to stop asexual replication of 
parasite 
Robenidine Robenz multiple stages Prevent asexual replication in E. 
tenella (192) 
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Table 1.2 Anticoccidial Properties of Botanicals Modified from (4) 
Botanicals Active ingredients Mode of 
action 
Species 
studied  
Affected 
parameters 
Ageratum 
conyzoides 
flavonoids oxidative 
stress 
E. tenella ¯ OC 
­ WG 
Carcia papaya Papaine Sporozoite 
degradation 
E. tenella ¯ OC 
Cyamopsis 
Tetragonoloba 
Glacatomannans and 
saponins 
Binding with 
sterol 
molecules 
present on 
cell 
membrane 
E. tenella ¯ OC 
 
Linum 
usitatissimum  
N-3 fatty acids  Oxidative 
stress 
E. tenella ¯ LS 
 
Leninus 
edodes and 
Tremella 
fuciformis  
Polysaccharide 
extracts 
Immune 
stimulation 
E. tenella ­ WG 
Olea euopea Maslinic acid Anti-
inflammatory 
& 
antioxidant 
properties  
E. tenella ¯ OC, LS 
­ WG 
 
Pinus radiate 35% condensed 
tannins 
Damage of 
sporozoite 
cytoplasm 
E. 
acervulina, 
E. maxima, 
E. tenella  
¯ 
Sporulation 
Passum 
sativum  
 
Antibody fragments Inhibition of 
sporozoites  
E. tenella ¯ 
Sporozoite 
infectivity  
Tulbaghia Cysteine sulphoxide, 
bis-disulphide 
Oxidative 
stress 
Mixed 
infection  
¯ OC 
Vitis vinifera Tannins Oxidative 
stress 
E. tenella ¯ M, LS 
­ WG 
 
Vernonia 
amygdalina 
Vernoside Oxidative 
stress 
E. tenella ¯ OC 
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Table 1. 3: Probiotic in vivo Effects on Eimeria Infections 
     
Probiotic strain Infeed/water Eimeria Result Reference 
Bifidobacterium animalis DSM 16284, 
Lactobacillus salvarius DSM 16351, 
Enterococcus faecium DSM 21913 
Water 
Eimeria 
acervulina, 
E. maxima 
,E. tenella 
¯OC, ¯Jejunum 
LS 
(185) 
Lactobacillus acidophilus, 
Lactobacillus casei, Enterococcus 
faecium and Bifidobacterium bifidium 
Feed 
 
E. 
acervulina, 
E. maxima, 
E. tenella, 
E. mitis, E. 
brunetti, 
and E. 
praecox 
¯LS, ­WG (23) 
Bacillus subtilis (15AP4, Bs27, 
Bs278) Feed 
 
E. maxima ¯LS, ­WG (130) 
Pedococcus acidilactici, 
Saccharomyces boulardii Feed 
E. 
acervulina, 
E. tenella 
¯OC (131) 
Lactobacillus acidophilus, 
Lactobacillus rhamnosus, 
Bifidobacterium thermophilum, 
Enterococcus faecium 
Feed  
 
E. 
acervulina ¯OC (59) 
Bifidobacterium animalis DSM 
16284, Lactobacillus salvarius DSM 
16351, Enterococcus faecium DSM 
21913 
Feed 
E. 
acervulina, 
E. maxima 
and E. 
tenella 
¯FCR (7) 
Bifidobacterium animalis DSM 16284, 
Lactobacillus salvarius DSM 16351, 
Enterococcus faecium DSM 21913 
Feed /water  
E. 
acervulina, 
E. maxima, 
and E. 
tenella 
¯OC 
(84) 
Lactobacillus acidophilus, 
Lactobacillus rhamnosus, 
Bifidobacterium thermophilum, 
Enterococcus faecium 
Feed 
 
E. 
acervulina, 
E. tenella 
¯OC, ¯LS (217) 
Lactobacillus plantalum CMU-FP002 
 
 
Feed 
 
 
E. tenella 
¯OC (29) 
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    Table 1.4. Virulence Factors of NE-associated C. perfringens 
  References 
Factor  Supporting [Against] 
Toxins Genes   
α-toxin plc (9, 47, 73, 104, 139)  (122) 
NetB netB (82, 121, 123, 204, 
210, 213)  
 (46) 
Perforin Perforin  (225)  
Beta 2 toxin cpb2  (26, 76, 99, 127, 143) (46, 56, 69, 146, 226) 
Entero toxin   (55) (69)  
Tle gene present  tle (27, 48)   
Other    
Intraspecific growth-
inhibition abilities 
Bactericins   (21, 221)  
Collagenolytic 
enzymes 
Damage extracellular 
matrix of host   
(163)  
Adhesion to 
extracellular matrix 
molecules (ECMM) 
cnaA  (147, 240)  
Quorum sensing- 
toxin production  
Agr-like QS sensing  (259)  
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CHAPTER II 
EVALUATION OF INTERVENTIONS IN EXPERIMENTAL NECROTIC ENTERITIS 
MODEL 
 
 
Introduction 
 Necrotic enteritis (NE) is a multifactorial disease typically characterized by an over-
growth of Clostridium perfringens (142). This Gram-positive, spore forming bacterium is a 
common inhabitant in the ceca of healthy chickens (235). However, pre-disposing stressors 
including specific dietary changes and Eimeria infection may cause a shift in the intestinal 
environment and allow C. perfringens to establish itself in proximal segments of the intestine. 
The toxins produced during opportunistic toxicoinfection by C. perfringens have been 
demonstrated to cause significant nutrient malabsorption and intestinal necrosis (47, 157, 199, 
222). Clinical NE outbreaks often result in significant mortality, while the subclinical form of 
this disease has been demonstrated to be associated with reduced performance (46, 167). 
 Dietary prebiotics are non-digestible feed ingredients that selectively promote the growth 
or activities of beneficial microorganisms in the host’s gastrointestinal tract (85). One example of 
a commercially available prebiotic for poultry is a yeast cell wall product. Dietary inclusion of 
yeast cell wall prebiotics has been shown to improve broiler performance (75, 169, 195, 261). 
These products are attractive feed additives because they have been demonstrated to have 
immunomodulatory characteristics and provide competitive binding sites for pathogenic bacteria 
(12, 75). Administration of prebiotics in-feed has been shown to improve immune responses to 
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Eimeria tenella infections (74). It was shown the yeast cell product improved performance as 
well improve immune function during coccidial infections (86).  
 Botanical additives are blends of plant essential oils extracted from aromatic plants using 
non-aqueous solvents (24). These oils were shown to have anti-protozoal characteristics against 
Plasmodium, the causative agent of malaria (164). Botanical Artemisia annua, Quisqualis indica, 
Sophora flavescens, grape seed extract, and oregano oils have been shown to have activity 
against Eimeria in vivo through immunomodulation and amelioration of intestinal damage from 
coccidial infections (15, 83, 244, 258).  
 NE was a relatively rare disease when subtherapeutic antibiotics were included in poultry 
feed (103), as producers were able to prevent disease and manage losses using antibiotics. As 
consumer preferences shift and changes in regulation of antibiotic-use, the antibiotic-free poultry 
market has rapidly grown. Because of their antimicrobial activities and effects in improving 
intestinal health, functional feed ingredients, including dietary prebiotics and botanical extracts, 
are widely seen as potential alternatives to antibiotics in the prevention and management of 
gastrointestinal disease in poultry (16, 58, 202, 235). In this study, we evaluated the effect of the 
administration of a Mannanoligosaccharide dietary prebiotic derived from inactivated 
Saccharomyces cerevisiae and a botanical essential oil extract on growth performance, gross 
intestinal lesions, and gastrointestinal counts of C. perfringens in broiler chicks experimentally 
co-infected with Eimeria spp. and C. perfringens. 
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Materials and Methods 
 288 day of hatch male broiler chicks (Cobb) were weighed, randomly assigned to 
treatment pens of similar starting weight, and placed into battery brooder pens with 6 birds per 
pen. There were six treatments with eight replicate pens of each treatment. The control 
treatments were: uninfected with Eimeria or C. perfringens, infected with only C. perfringens, 
infected with both Eimeria and C. perfringens. The other three treatments were all infected with 
Eimeria and C. perfringens but one was given BMD in feed (40 g/ton), one prebiotic (453 g/ton) 
and the last one was given botanical Essential Oil Extract (680 g/ton). Chicks were fed a 
commercial-type broiler mash diet formulated to meet or exceed NRC requirements (1). Birds 
were placed on experimental diets starting Day 0. Experimental diets were prepared as single 
basal ration with experimental treatments blended as directed by the manufacturers’ 
recommendations. Feed and water were administered ad libitum. Body weight, body weight gain, 
feed consumption, feed conversion, and mortality were monitored during the 28-day course of 
the study. All mortality was necropsied and inspected for necrotic enteritis. Research animals 
were given access to feed and water ad libitum and cared for in accordance with the Texas A&M 
University Institutional Animal Care and Use Committee (IACUC). Birds were raised in battery 
cages in BSL-2 isolation rooms at Texas A&M Vet Med Park. 
 Necrotic enteritis was induced using co-infection with Eimeria and C. perfringens. 
Broiler chicks were administered 103 oocysts/mL using a commercial vaccine containing non-
attenuated live oocysts of Eimeria acervulina, E. maxima and E. tenella at 14 d post-hatch and 3 
mL of C. perfringens culture (107 CFU mL-1) at 19, 20, and 21 d post-hatch by oral gavage 
(103). Sterile water or culture broth were used as mock infections as appropriate. C. perfringens 
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was cultured using fluid thioglycolate medium (FTM) anaerobically (Coy Laboratory Products, 
Inc).  
 At 21 d post-hatch, three broilers from each pen were selected randomly, euthanized, 
weighed, and necropsied for scoring of gross intestinal lesions. If there are fewer than 3 birds 
remaining, all remaining birds in the pen were selected. Gross intestinal lesions were scored in 
the jejunum at Meckel’s diverticulum for gross intestinal lesions. The scoring were based on a 0 
to 3 score: 0 = normal; 1 = thin-walled or friable; 2 = focal necrosis or ulceration; and 3 = large 
necrotic patches/ “Turkish towel” appearance (262). 
 Sections of the jejunum and ileum were dissected from each sampled broiler; pooled by 
pen; homogenized and diluted using FTM; and plated for enumeration using Tryptose Sulfite 
Cycloserine – Egg Yolk (TSC-EY) agar incubated anaerobically at 37oC. C. perfringens was 
selectively enriched using FTM and Iron Milk Medium (IMM). 
 Data were analyzed using ANOVA with the pen as the experimental unit. Significant 
differences between treatment groups were determined using Duncan’s multiple-range test using 
α = 0.05. Clostridium perfringens counts were log10 transformed prior to statistical analysis. 
Samples for which no colonies appeared on the enumeration plates but were positive by selective 
enrichment were assigned the limit of detection for the assay (2 log10 CFU g-1).  
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Results  
 There were no significant differences in body weights observed between any treatment on 
Day 0 (P=0.189), 14 (P=0.666), or 19 (P=0.111) (Table 2.1). However, a significant effect of the 
treatments on body weight was observed on Day 21(P=0.002) and Day 28 (P=0.0397). On Day 
21, body weights were significantly lower for the Control Infection Group (co-infected) and for 
broilers receiving the prebiotic and botanical extract when compared to the uninfected broilers, 
while the body weight of broilers infected with only C. perfringens and treated with BMD were 
not significantly different than the body weights of uninfected birds. On Day 28, body weights of 
only the Control Infection (co-infected) and BMD bird body weights were significantly different 
from each other, while the remaining treatment groups were similar to both treatments.  
 The treatments were observed to have a significant effect on feed conversion ratio (FCR) 
of broilers for Day 0-21 (P = 0.047) and Day 0 – 28 (P=0.045) (Table 2.2). FCR was observed to 
be significantly higher for Control Infection (co-infected) birds compared to the uninfected, C. 
perfringens only-infected, and BMD treated birds on D 0-21 (P=0.0002) (Table 2.2). The FCR 
for D 0-21 in prebiotic and botanical birds were not observed to be different for any treatment. 
The FCR for D 0-28 was significantly higher in the prebiotic birds compared to the uninfected, 
C. perfringens only birds and BMD birds (Table 2.2). No significant differences in FCR D 0-28 
was observed between co-infected birds and any other treatment.  
 There were no NE-related mortalities in the un-infected birds (MOCK). No significant 
differences in NE mortality were observed between the C. perfringens only (CPI), BMD and un-
infected birds (MOCK). The mean NE-related mortality was significantly higher in the co-
infected (CON) (30% mortality) and the botanical (BOT) (27% mortality) birds compared to the 
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C. perfringens only (CPI) and BMD birds (P<0.05) (Figure 2.1). No differences were observed 
in mean NE mortality of the prebiotic birds compared to the botanical, or co-infected birds.  
 Over all, lesion scores were higher in the jejunum than the duodenum for all treatments. 
One exception was the C. perfringens only birds, which had higher scores in the duodenum 
compared to the jejunum.  
 The treatments were observed to have a significant effect on gross duodenal lesions was 
observed (P<0.001) (Figure 2.3A). No significant differences in mean duodenum NE lesions 
were observed in C. perfringens only-infected (CPI), BMD and un-infected birds (MOCK) 
(Figure 2.3A). However, the aforementioned treatments had significantly lower mean lesions 
than the co-infected (CON), prebiotic (PRE) and botanical (BOT) treatment birds (P<0.001) 
(Figure 2.3A). 
 The treatments were observed to have a significant effect on gross jejunal lesions 
(P<0.001) (Figure 2.3B). No significant differences in mean jejunum NE lesions were observed 
in C. perfringens only-infected (CPI), BMD and un-infected birds (MOCK) (P<0.001) (Figure 
2.3B). No differences were reported in the co-infected (CON), prebiotic (PRE) and botanical 
(BOT) treatments mean jejunum NE lesion scores.   
 No lesions were observed in the un-infected birds (MOCK) in both the duodenum and 
jejunum.  
 In general, C. perfringens counts were higher in the jejunum than in the duodenum, 
among all treatments.  
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 Treatments were observed to have a significant effect on duodenal C. perfringens counts 
(P<0.001) (Figure 2.2A). Duodenal C. perfringens counts in co-infected (CON), prebiotic (PRE) 
and botanical (BOT) treatments (Figure 2.2A). C. perfringens only birds (CPI) had significantly 
different duodenal C. perfringens than all other treatments (P<0.001) (Figure 2.2A).  BMD and 
un-infected birds (MOCK) did not significantly differ in duodenal C. perfringens but were lower 
than all other treatments (P<0.001) (Figure 2.2A).  
 Treatments were observed to have a significant effect on jejunal C. perfringens counts 
(P<0.001) (Figure 2.2B). Jejunal C. perfringens counts were significantly lower in BMD and un-
infected birds compared to other treatments (MOCK) (P<0.001) (Figure 2.2B). The C. 
perfringens only birds had jejunal C. perfringens counts that were significantly lower than the 
botanical and co-infected birds, but similar to prebiotic (P<0.001) (Figure 2.2B).  
 All birds that were not infected with C. perfringens had no colonies were observed on the 
plates. All birds that had been infected with C. perfringens had a positive for enrichment, even if 
no colonies were observed on the plates. 
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Discussion   
 Necrotic enteritis (NE) is a multifactorial disease often characterized by an over-growth 
of Clostridium perfringens (142). This bacterium is a common inhabitant of the ceca of healthy 
chickens. However, stressors including dietary changes and Eimeria infections may cause a shift 
in the intestinal environment which allows C. perfringens to establish itself in proximal segments 
of the intestine and cause significant nutrient malabsorption from toxin production and intestinal 
necrosis (47, 157, 199, 222). Clinical NE may result in significant morality, while the subclinical 
form of this disease is associated with reduced performance (46, 167).  
 Since NE is a multifactorial disease, understanding the relationships between each 
predisposing factor is crucial to developing relevant experimental models (157, 177, 236). Not 
all C. perfringens isolates are able to induce NE, so using a pathogenic strain is important to 
inducing the disease (21, 210, 224). Therefore, we used C. perfringens isolated from a natural 
necrotic enteritis outbreak. We also used coccidia, a common predisposing factor, which induces 
intestinal damage and allows for colonization of C. perfringens (251).  
 The Clostridium perfringens used in this model has alpha-toxin and Net-B genes. Both of 
these toxins have been associated with NE-inducing C. perfringens (27, 121). The weights and 
FCR of C. perfringens only birds were not significant from uninfected birds at any point. 
However, there was mortality associated with NE in this treatment, although it was significantly 
lower than the co-infected birds. The CFU counts in the duodenum and jejunum in C. 
perfringens were significantly different than the uninfected birds and the co-infected birds. Due 
to the lack of performance differences, but NE mortality in C. perfringens only birds, it would 
seem this presentation of NE is more acute. Both chronic and acute forms if the disease have 
been reported (47, 149, 235).  
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 Although birds were infected with 10X of a non-attenuated Eimeria vaccine, no weight 
differences between the ones infected with coccidia and those without (Day 19-one week after 
Eimeria administration). The Eimeria infection was a week before birds were weighed at D 19, 
which would be enough time for weight reduction from Eimeria (154). This infection was mild, 
so no significance in performance loss from Eimeria was observed, but enough intestinal damage 
to predispose to NE.  This is important for the NE model because if there is too heavy infection 
with coccidia, C. perfringens will not have an intestinal epithelium to bind to and subsequently 
cause NE (251). 
 Treatments were observed to have a significant effect on body weights on D 21 and D 28. 
The uninfected controls were significantly heavier than the co-infected birds on D 21. Previous 
researchers have demonstrated similar results when birds are infected with both Eimeria and C. 
perfringens (40, 177, 253). The C. perfringens only and BMD birds were similar weights to the 
uninfected controls on D 21. On Day 21, when the levels of C. perfringens would be the highest 
due to three prior C. perfringens inoculations, the birds were similar weights with the uninfected 
and the C. perfringens only birds. BMD has been shown to significantly reduce C. perfringens 
levels even without a challenge (66, 67, 216). 
 Birds only infected with C. perfringens were similar in body weights on Day 21 and 28 to 
the uninfected controls. Previous research with 5 different strains of C. perfringens showed 
significant differences in weights and FCR in only one of the strains compared to the un-infected 
controls (28). Other researchers have observed more severe weight suppression and necrotic 
lesions in birds given only C. perfringens (10, 25, 49). Perhaps the virulence of the bacteria 
dictates some of the weight reduction in treatments only given C. perfringens. The toxins in the 
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broth with administered C. perfringens could also be a factor that allows induction of disease in 
the absence of predisposing factors (9).  
 The co-infected birds had significantly higher FCR compared to the C. perfringens only, 
uninfected and BMD birds during D 0-21. The prebiotic and botanical were not significantly 
different from either of those groups. BMD birds had similar FCR to the uninfected and C. 
perfringens only birds. The FCR in co-infected birds were similar to all treatments D 0-28. The 
only treatments that were significantly different FCR D 0-28 were BMD, uninfected, C. 
perfringens only compared with the prebiotic. This could be explained due to the recovery period 
D 21-28 and surviving bids were able to over-come the challenge, resulting in similar FCR. In 
our study, C. perfringens alone did not have an impact on FCR compared to uninfected birds D 
0-21. This has been observed by others as well, and has been suggested to indicate a subclinical 
form of necrotic enteritis (81).  
 C. perfringens counts in both the duodenum and jejunum were significantly lower in the 
C. perfringens only birds compared to those co-infected with Eimeria. This is makes sense since 
intestinal damage is required for successful colonization of the C. perfringens in those regions of 
the intestine (253). C. perfringens is commonly found in the ceca and ileum of birds, but in much 
lower numbers in the duodenum, because of the low pH which doesn’t favor colonization (176).  
 Bacitracin Methylene Dialicylate (BMD) was effective at reducing C. perfringens counts. 
Based on these results and the reduction in NE lesions, it seems that the C. perfringens strain 
used in our study is sensitive to BMD, but in vitro studies could be done to confirm this.   
 The essential oil botanical did not appear to reduce C.  perfringens counts in duodenum 
or jejunum. Birds given some essential oil blends have been shown to  have lower C. perfringens 
counts (156).  However, these birds were not experimentally infected, but rather just naturally 
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exposed to C. perfringens through the litter.  It seems plausible these products work more 
effectively when the challenge is low, and perhaps even on a subclinical level of NE. Other 
researchers demonstrated significant reduction in NE mortality in birds given an essential oil 
blend, and NE was induced through dietary fishmeal, coccidia vaccine and C. perfringens 
administration (223). A difficulty with using essential oils, is the variation in proprietary blends 
used. Understanding individual effects in reducing NE of each compound in a blend may help to 
better optimize the use of these products.  
 Birds that were not infected with C. perfringens did not have any NE lesions or NE 
associated mortality. These had significantly lower C. perfringens counts, which indicates there 
wasn’t significant cross contamination between the battery cages. C. perfringens is ubiquitous in 
the soil, environment and commonly isolated in chicken intestines (52, 53, 160, 199). However, 
induction of NE requires predisposing factors and presence of C. perfringens alone doesn’t 
reliably produce the disease (58).  
 The prebiotic additive did not appear to have a positive effect on gross NE lesion scores. 
Our results were similar to other researchers that showed NE mortality, FCR, BW and lesion 
score was not different in positive control and prebiotic-fed birds in a NE model system (103). 
The model used in the previously mentioned research was similar to our model with Eimeria 
infection a week before C. perfringens inoculation but they included dietary fishmeal as well 
(103). 
 With 30% mean NE mortality in the co-infected controls, we can say that the NE model 
was strong and successful. The C. perfringens only birds did have some NE mortality, but was 
statistically similar to the uninfected controls. This would be in line with what other researchers 
identify as subclinical NE, focal necrosis in intestines with little to no mortality and performance 
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may not be significantly influenced (9, 104, 235). While it does not seem likely that one single 
intervention will be able to replace BMD or other in-feed antibiotics for prevention of NE, it did 
appear that the two products tested may help to improve performance during and after a NE 
challenge. BMD was the only tested product that significantly reduced NE mortality, C. 
perfringens counts or gross lesions. The bird weights were similar on Day 28 in botanical, 
prebiotic and BMD treatment. FCR was similar between the botanical, prebiotic and BMD 
treatment for D 21 and 28. So while the products tested may not reduce C. perfringens counts, 
NE lesions or NE mortality, they do promote weights in surviving birds similar to that of BMD. 
All products added, were included in the feed from day of hatch, so none were used on a 
treatment basis. However, the challenge in this model is very strong, and so testing potential 
additive effects of the products may improve the NE parameters examined. As antibiotic free 
poultry production becomes more common, the search for viable alternatives is crucial.  
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Table 2.1 Average Body Weight of Broiler Chickens  
Treatment  Body Weight (kg) 
Product Infection  D 0 D 14 D 19 D 21 D 28 
Untreated Uninfected  0.043 0.415 0.786 0.873a 1.351ab 
Untreated Clostridium4  0.044 0.416 0.718 0.861ab 1.264ab 
Untreated Co-infection5  0.044 0.414 0.694 0.761c 1.107b 
BMD1 Co-Infection  0.044 0.435 0.724 0.861ab 1.352a 
Prebiotic2 Co-Infection  0.044 0.422 0.705 0.766c 1.093ab 
Botannical3 Co-Infection  0.044 0.420 0.699 0.795bc 1.154ab 
        
 P–value  0.189 0.666 0.111 0.002 0.0397 
 Pooled SEM  0.000 0.01 0.024 0.022 0.0343 
a-c Different superscripts indicate means are significantly different (P ≤ 0.05) 
1Bacitracin Methylene Dialicylate; 2 PREBIOTIC; 3BONTANICAL EXTRACT  
4 Infection with C. perfringens; 5Coinfection with Eimeria spp. and C. perfringens 
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Table 2.2. Feed Conversion of Broiler Chickens  
Treatments  FCR (Feed:Gain) 
Product Infection  D 0 -21  D 0 -28 
Untreated Uninfected  1.263b  2.776b 
Untreated Clostridium4  1.263b  2.659b 
Untreated Co-infection5  1.505a  2.993
ab 
BMD1 Co-Infection  1.226b  2.555b 
Prebiotic2 Co-Infection  1.370ab  4.038a 
Botannical3 Co-Infection  1.376ab  3.053ab 
      
 P-value  0.0002  0.0048 
 Pooled SEM  0.047  0.045 
a-c Different superscripts within a column indicate means 
are significantly different (P ≤ 0.05) 
1Bacitracin Methylene Dialicylate; 2 PREBIOTIC; 
3BONTANICAL EXTRACT 
4 Infection with C. perfringens; 5Coinfection with Eimeria 
spp. and C. perfringens5 
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Figure 2.1. Necrotic Enteritis Mortality. Mortality (%) due to necrotic enteritis post 
experimental infection. Mortality reported as mean ± SEM from 8 pens per treatment. CON, 
control infection; CPI, C. perfringens-only infected; BMD, BMD treated; PRE, prebiotic treated; 
BOT, botanical extract treated; MOCK, mock infection. Different letters above bars indicates 
means are significantly different (P < 0.05).  
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Figure 2.2. Enumeration of Clostridium perfringens from Broiler Chickens. C. perfringens 
were enumerated from (A) duodenum and (B) jejunum of broiler chickens at 8 hours post 
infection on day 21 post-hatch. Counts are reported as the mean ± SEM log10 CFU g-1 digestive 
from pooled contents from 3 broilers pen from 8 pens per treatment. CON, control infection; 
CPI, C. perfringens-only infected; BMD, BMD treated; PRE, prebiotic treated; BOT, botanical 
extract treated; MOCK, mock infection. Different letters above bars indicate means are 
significantly different (P < 0.05).  
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Figure 2.3. Necrotic Enteritis Lesion Scores. Gross intestinal lesions in the (A) duodenum and 
(B) jejunum were scored 8 hours post infection on day 21 post-hatch. Lesion scores are reported 
as the mean ± SEM from 3 broilers pen from 8 pens per treatment. CON, control infection; CPI, 
Clostridium-only infected; BMD, BMD treated; PRE, prebiotic treated; BOT, botanical extract 
treated; MOCK, mock infection. Different letters above bars indicate means are significantly 
different (P < 0.05). 
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CHAPTER III 
LONGITUDINAL RESPONSE OF COMMERICAL BROILER OPERATIONS TO 
BIOSHUTTLE ADMINISTRATION 
 
 
Introduction 
 Coccidiosis, caused by intracellular intestinal parasitic Eimeria spp., poses a substantial 
cost to the poultry industry which has been estimated to have a total worldwide annual cost of $3 
billion (USD). The sources of costs or economic losses associated with coccidiosis include the 
costs of coccidiosis control measures; predisposition to secondary disease such as necrotic 
enteritis; and morbidity and  mortality (179, 254).  
Coccidia are primarily controlled through the use of in-feed anticoccidial drugs or 
vaccination with live Eimeria oocysts (172). In-feed anticoccidials were used widely, but due to 
the few products commercially available, concerns over increases in drug resistance have 
continued to rise (5). Because they are composed of drug sensitive Eimeria, interest in the use of 
coccidia vaccines to potentially combat drug resistance has increased (150, 249). The use of live-
Eimeria vaccines alone has been demonstrated to restore anticoccidial drug sensitive Eimeria 
populations on poultry farms (36, 148, 171). This succession of Eimeria populations is thought 
to be the result of competition between drug sensitive vaccine strains and drug resistant Eimeria 
previously present in the litter.  
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 Although they can be used alone, vaccines can also be administered as part of a bioshuttle 
program in which an ionophore, or other low-dose anticoccidial drug, is administered in-feed 
during the grower and finisher diet phases or later. The ionophores are not administered until the 
grower ration, so as to not interfere with initial cycling of the vaccine Eimeria. Bioshuttle 
programs can be administered to mitigate Eimeria vaccine-related performance losses and 
potentially reduce the risk of secondary diseases such as necrotic enteritis. However, very little 
research has been performed on the effects of bioshuttle use. Additionally, although the use of 
vaccines alone has been demonstrated to restore populations of drug sensitive Eimeria, it is 
unknown whether drug-sensitive Eimeria populations are similarly restored during the use of a 
bioshuttle in commercial settings. In this study, we collected data from a commercial integrator 
to develop a longitudinal profile of the response of broiler chicken production before, during, and 
after bioshuttle application as part of the drug/vaccine program of a commercial integrator over a 
12-month period.  
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Materials and Methods  
 The overall drug program used by the integrator through 2016 (Table 4.1) was divided 
into three periods: Pre/Before the bioshuttle; During the bioshuttle, and Post/after the bioshuttle. 
Before the bioshuttle, the birds were placed on a chemical program: nicarbazin in the starter diet, 
decoquinate in the grower and finisher one diets, and no anticoccidial drug in the finisher two 
diet. During the bioshuttle program, the birds were vaccinated (Coccivac B52, Merck Animal 
Health, Millsboro, DE) for coccidia in the hatchery, and administered an ionophore program: 
Salinomycin (Huvepharma, Peachtree City) in the grower and finisher one diets, and no 
anticoccidial drug in finisher two diet. After the bioshuttle, the anticoccidial program was narasin 
with nicarbazin in the starter, grower and finisher one diet and nothing in the finisher two. 
 Aggregate production data including live weights, adjusted FCR, and livability from ten 
broiler complexes were provided by a commercial integrator. Performance data was collected 
from each complex before, during and after the bioshuttle. The time period sampled was chosen 
to ensure that all birds processed were only exposed to one coccidia control method. Body 
weights collected were live body weight measured at the processing plant. Mortality corrected 
FCR was calculated from farm weights and feed consumption. Livability was calculated from 
birds placed on Day of hatch and those that arrive live at the plant. Standard cost deviations were 
calculated from the subtracting the final cost of the sold bird from the cost it took to raise it. A 
negative value indicates more money was made from selling the bird than it cost to raise the bird.  
 Coccidiosis lesion scores (i.e., gross lesions and microscopic E. maxima scores) were 
collected from posting sessions at all complexes during the 12-month data collection period. Six 
birds from each farm were sampled and examined for coccidia. These birds were randomly 
selected from a house of approximately 10,000 broilers. Ten farms with birds of different ages 
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were examined for each complex, for a total of 60 birds scored per complex before, during and 
after the bioshuttle. Gross lesion scores were determined using Johnson and Reid Method (1970) 
(113). Because of the low prevalence of gross E. maxima scores, microscopic scores were 
reported instead (22). Scrapings from the intestine near Meckel’s diverticulum were collected 
from each bird during posting session and were wet mounted onto a slide. Only E. maxima 
developmental stages were accounted for in the micro-scores. Briefly, 0 indicated no stages; 1, 
1–20 stages per 10X objective field; 1: 1–20 stages; 2: 21–50 stages; 3: 51–100 stages; and 4: too 
numerous to count. Approximately 10 fields of vision were observed per bird. 
 Performance data from ten broiler complexes was collected for one week of processing 
before, during and after the integrator’s bioshuttle program. Coccidiosis lesions were reported for 
posting sessions during respective time points. Data was compiled from each complex and 
analyzed using ANOVA, and significantly different means were separated using Duncan’s 
Multiple Range Test using α = 0.05. Additionally, data from super bird (processed average 9 
pounds) and tray-pack bird (processed average 7 pounds) complexes were analyzed separately. 
Body weights were averaged for each complex and  reported as mean ± SEM lbs of body weight 
at processing. . ADG is shown as mean ± SEM lbs per bird per day of weight gain. 
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Results 
 A significant effect of the drug program period was observed on body weights (BW) of 
super birds (P<0.001) (Figure 3.1A) and tray-pack birds (P<0.001) (Figure 3.1C). For both 
super and tray-pack birds, BWs were lowest for birds processed during the bioshuttle application 
and greatest for birds processed in the period after bioshuttle application.  
 A significant effect of the drug program period was also observed for average daily gain 
(ADG) of super birds (P<0.001) (Figure 3.1B) and tray-pack birds (P<0.001) (Figure 3.1D). 
ADG was lowest for both super and tray-pack birds during the bioshuttle application period. 
ADG was similar in the periods before and after bioshuttle application for super birds. However, 
for tray-pack birds, ADG was greater during the period after the bioshuttle was administered 
than the period before the bioshuttle was administered.  
 A significant effect of drug program period was observed on mortality corrected feed 
conversion ratio (FCR) in super birds (P<0.001) (Figure 3.2A) and tray-pack birds (P<0.001) 
(Figure 3.2B). The FCR were significantly higher during bioshuttle, than before and after in 
both super and tray-pack birds.  
 A significant effect of drug program period was observed on livability of super birds 
(P=0.0324) but was not observed for tray-pack birds (P=0.179) (Figure 3.3). The mean livability 
of super birds was significantly higher before compared to during the bioshuttle, but livability 
after bioshuttle application was similar to the other periods.  
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 There was no observed effect of drug program period in standard cost deviation of super 
birds (P=0.988) (Figure 3.4A). However, there was an observed effect in tray-pack birds 
(P<0.001) (Figure 3.4B). Mean standard cost deviation was significantly higher during 
bioshuttle compared to before and after.  
 A significant effect of the drug application period was observed on the total prevalence of 
Eimeria acervulina lesions (P=0.05) (Figure 3.5A). and in the distribution of lesion scores 
(P=0.02) (Figure 3.5B) for super birds. The prevalence of E. acervulina lesions was significantly 
higher in super birds for the periods during and after bioshuttle application than for the period 
before the bioshuttle was administered.  The highest lesion score reported across all periods for 
super birds was +2, and no significant difference was observed in the percentage of super birds 
with +2 lesion during any time point. However, a significant difference was observed in the 
percentage of birds with a score of +1 was higher during and after the bioshuttle compared to the 
period before. A significant effect of the drug treatment period on E. acervulina lesion 
prevalence was not observed before, during or after the bioshuttle in tray-pack birds (P=0.803) 
(Figure 3.5C). The highest lesion score reported in these birds was a +3. However, there were no 
differences in the percentage of tray-pack birds with any lesion score value (Figure 3.5D).  
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 A significant effect on drug program period was observed on prevalence of microscopic 
E. maxima in super birds (P=0.045) (Figure 436A). Prevalence was significantly higher in super 
birds during the bioshuttle compared to before and after. All scores (0-4) were reported in super 
birds. However, the distribution was only significant in lesion score of +1. The percentage of 
birds with lesion score +1 was significantly higher in super birds during the bioshuttle (P-0.006) 
(Figure 3.6B). There was a significant effect on drug program period observed on prevalence of 
microscopic E. maxima in tray-pack birds (P=0.036) (Figure 3.6C). The prevalence was 
significantly higher during the bioshuttle compared to before and similar to after the bioshuttle in 
tray-pack birds. All scores (0-4) were reported in tray-pack birds. The only significant 
differences in lesion distribution were observed for lesion score of +2. The percentage of birds 
with +2 lesion score was significantly higher during the bioshuttle compared to before and 
similar to after bioshuttle in tray-pack birds (P=0.023) (Figure 3.6D). No other significant 
differences were observed in the other lesions.  
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Discussion  
 Due to their ubiquity in commercial poultry production, control of these parasites is 
required for [sustainable poultry production. Traditionally this parasite has been controlled using 
in-feed anticoccidials or vaccination (154). Vaccination with live coccidiosis vaccines has 
become much more popular (35).  Administration of vaccines exposes birds to low number of 
oocysts in order to stimulate development of protective immunity. The Eimeria oocysts used in 
live vaccines are drug sensitive, so vaccine use allows introduction of drug sensitive Eimeria that 
could potentially out-compete the drug-resistant Eimeria already present in the chicken house 
(35, 36, 148). Indeed, the use of live-Eimeria vaccines alone has been demonstrated to restore 
anticoccidial drug sensitive Eimeria populations on poultry farms (36, 148, 171). 
Recently some poultry producers have begun to use a bioshuttle program, in which birds 
are vaccinated with a coccidia vaccine at day of hatch and then given an in-feed anticoccidial 
during the grower ration (usually the second week of life). Some researchers demonstrated 
Salinomycin administration almost completely suppressed oocyst production when oocyst 
vaccination alone had been implemented 4 flocks prior, indicating restoration of drug sensitivity 
(36). However, what wasn’t determined was if isolates that were concurrently exposed to 
Salinomycin and coccidia vaccines, known as a bioshuttle, would be sensitive to anticoccidial 
drugs in subsequent flocks. We wanted to determine the broiler performance and coccidiosis 
lesions before, during and after a bioshuttle and potential drug sensitivity in a field setting. To 
evaluate sensitivity of the Eimeria to the drugs, monitoring of bird performance as well posting 
birds to examine coccidia levels is commonly done by poultry producers. Although these 
variables are not stand-alone indicators of drug sensitivity, we used both to develop a profile for 
this particular broiler integrator. 
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Evaluating the lesions and performance before, during and after a bioshuttle program 
could therefore indicate potential increased drug sensitivity in a field setting.  
Different measurements of anticoccidial sensitivity have been debated as superior in the 
past (105, 187, 241). Generally gross lesion scores, weight gain and fecal oocyst counts are used 
to evaluate anticoccidial efficacy (102, 105, 113). Some debate the value of using lesion score 
alone because of differences in correlation with each Eimeria or mixed species (22, 42). 
However, in a field setting, measuring weight gain alone is difficult to make conclusions on 
anticoccidial sensitivity because of the confounding variables. In this study, we chose to 
incorporate performance parameters as well as coccidia lesions scores to evaluate drug 
sensitivity before, during and after a bioshuttle program. 
  Broiler performance (BW and ADG) in super and tray-pack birds before and after 
bioshuttle was significantly higher than during the bioshuttle. Super and tray-pack birds were 
significantly heavier after the bioshuttle compared to during and before. ADG was significantly 
increased in tray-pack birds compared to before and during the bioshuttle, but this was not seen 
in super-birds. The mortality adjusted FCR in super and tray-pack birds were significantly higher 
during the bioshuttle compared to before and after. Livability was significantly higher in super 
birds before the bioshuttle compared to during. No differences were observed after the 
bioshuttle. For tray-pack birds, no significant differences were observed in livability during any 
drug program period. Overall, measures of growth performance were worse during bioshuttle 
application than they were before and after.  
 Currently no data has been published during a bioshuttle. Additionally, no data has been 
published comparing broiler response before, during and after a bioshuttle. This limits our ability 
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to compare to other research, but since many poultry producers are beginning to use bioshuttle 
programs, data on the effects of this program should become more available.  
 In addition to being on a coccidia vaccine, birds during the bioshuttle are being grown 
during southern summer heat. Heat stress has been long known to be associated with poor bird 
performance (180). Therefore, it makes it difficult to determine the exact influence weather and 
coccidia vaccine have on performance during this time. During the spring and fall seasons, the 
birds do not have the weather pressure, which could also explain the improvement in weights and 
FCR before and after the bioshuttle. However, the winter time is most commonly associated with 
coccidiosis issues because of reduced ventilation, promoting better environmental factors for 
coccidia oocysts (96). 
 Drug program period did not have an influence on standard cost deviation in super birds. 
However, in tray-pack birds, the standard cost deviation was highest in birds during the 
bioshuttle compared to the other periods. In other words, the lower the cost deviation, the more 
economical it was to raise the birds. This observation does not appear to be coccidia related 
because prevalence of E. acervulina and microscopic E. maxima lesions were higher after the 
bioshuttle when compared to during. Therefore, it seems that this observation was related to 
weather and warm summers in the Southeastern United States would increase standard cost 
deviation.  
 Although they were generally similar, the differences in the super and tray-pack birds 
could be the differences in growing a chicken to 9 pounds verses 7 pounds and the physiological 
implications that could have. For instance, the older the bird gets, the more the FCR increases, 
decreasing economic value (97). This could explain why the standard deviation costs were higher 
in the super compared to the tray-pack birds during all time points.  
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Before the bioshuttle, the birds were on a chemical program (nicarbazin and 
decoquinate). Chemicals have a strong selection pressure than ionophores, and nicarbazin is has 
been shown to be a strong anticoccidial (19, 31, 212). This explains why the E. acervulina and 
microscopic E. maxima lesion prevalence was significantly lower in both super and tray-pack 
birds before the bioshuttle.  
Although not significant during and after, the prevalence of E. acervulina lesions was 
highest after the bioshuttle, when the birds were on a combination ionophore and chemical 
program. This was not predicted because during the bioshuttle, when the birds are vaccinated 
with live oocysts, would we expect to see the highest prevalence of E. acervulina lesions. This 
may be due to general anticoccidial activity of narasin and nicarbazin compared with the 
salinomycin (61, 191, 246).  
 Prevalence of E. acervulina lesions did not correlate with performance parameters in 
super birds during the sample periods. Prevalence of E. acervulina was the highest after the 
bioshuttle while body weights and ADG were significantly higher and mortality adjusted FCR 
the significantly lower during this period. The prevalence of E. acervulina lesions were not 
significantly different in the tray-pack birds, but the trends were similar to super birds. Although 
significant infection of E. acervulina can impair growth in birds, researchers have shown a lack 
of correlation with E. acervulina infection and bird performance reduction (42).  
 Prevalence of E. maxima microscopic lesions did correlate with performance parameters 
in super birds during the sample periods. When prevalence of E. maxima was highest, during the 
bioshuttle, the body weights and ADG were significantly lower. This relation in E. maxima 
prevalence and performance, although not significant, was also seen in the tray-pack birds. E. 
  50 
maxima is more pathogenic than E. acervulina and infections with this species often correlate 
with reduction in performance (42, 198).  
With the improvement in weight seen after the bioshuttle, it is tempting to predict 
sensitive coccidia out-competed the field strains, subsequently causing performance 
improvement when the winter coccidia control program was started.   
However, there was an increase in E. acervulina lesions after the bioshuttle. Although not 
significant, the prevalence was numerically higher after the bioshuttle. This higher prevalence of 
E. acervulina lesions would not indicate that drug sensitivity was restored after administration of 
bioshuttle.  
 Prevalence of microscopic E maxima was significant lower before and after the 
bioshuttle, with performance being the best during these times (BW, ADG, mort. adj. FCR). 
Because these species are more commonly associated with reduction in performance, we 
speculate these results indicate a drug sensitive Eimeria population after the bioshuttle.  
 The drug program period had a significant effect on performance, with the best bird 
performance after the bioshuttle in both super and tray-pack birds. The prevalence of E. 
acervulina lesions was not correlated with broiler performance in either the super or tray-pack 
birds. However, the prevalence of microscopic E. maxima appeared to be related to the broiler 
performance in both super and tray-pack birds. This should be investigated with more sampling 
points to determine if the interaction is significant. Utilizing production data allowed a larger 
scale analysis of a bioshuttle program in the field. In addition to this work, examining the drug 
sensitivity of Eimeria isolates in a laboratory setting would help to determine drug sensitive 
populations, and further indicate an effect the bioshuttle may have on Eimeria populations. This 
would also take out the confounding variable of the weather during the different growing times.  
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Table 3.1. Drug1/Vaccine Program (2016) 
Program phase 
(months)2 
Pre Bioshuttle 
(Jan – Apr) 
Bioshuttle 
(May – Aug) 
Post Bioshuttle 
(Sep – Dec) 
Diet Phase    
Starter  
(d 0 – 14) 
Nicarbazin 
BMD3 
Coccivac-B524 
Virginiamycin 
Nicarbazin 
Narasin 
Grower  
(d 14 – 27) 
Deccox 
BMD 
Salinomycin 
Virginiamycin 
Nicarbazin 
Narasin 
Finisher 1 
(d 28 - 48) 
Deccox 
BMD 
Salinomycin 
Nicarbazin 
Narasin 
Finisher 2 
(d 48 - d59) 
Virginiamycin Virginiamycin Virginiamycin 
1 all drugs administered in-feed; 24 month phases (inclusive);  
3 bacitracin methylene disalicylate; 4 vaccination in-hatchery 
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Figure 3.1: Body Weights and Gain. (A) Live Body Weights and (B) Average Daily Gain 
(ADG) of super birds(C) Body weight and (D) ADG of tray-pack birds. Body weight is shown as 
mean ± SEM lbs of body weight at processing. ADG is shown as mean ± SEM lbs per bird per 
day of weight gain. Different letters above bars indicate means are signficiantly different (P < 
0.05).  
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Figure 3.2: Feed Conversion Ratio. Mortality corrected feed conversion ratio (feed:gain) of (A) 
super birds and (B) tray-pack birds. FCR is shown as mean ± SEM feed:gain. Different letters 
above bars indicate means are signficiantly different (P < 0.05).  
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Figure 3.3: Livability. Livability (%) of (A) super birds and (B) tray-pack birds. Mean ± SEM 
% livability shown. Different letters above bars indicate means are signficiantly different (P < 
0.05).  
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Figure 3.4: Standard Cost Deviation. Standard cost deviation of (A) super birds and (B) tray-
pack birds. Mean ± SEM % deviation is shown. Different letters above bars indicate means are 
signficiantly different (P < 0.05).  
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Figure 3.5: Gross Eimeria acervulina Lesions. (A) % of total birds with lesions and (B) 
distribution of lesion scores for super birds. (C) % of total birds with lesions and (D) distribution 
of lesion scores for tray-pack birds. Light gray bars, before; dark gray bars, during; and black 
bars, after. Different letters above bars indicate means are signficiantly different (P < 0.05).  
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Figure 3.6: Microscopic Eimeria maxima. (A) % of total birds with lesions and (B) distribution 
of lesion scores for super birds. (C) % of total birds with lesions and (D) distribution of lesion 
scores for tray-pack birds. Light gray bars, before; dark gray bars, during; and black bars, after. 
Different letters above bars indicate means are signficiantly different (P < 0.05).  
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CHAPTER IV 
EVALUATION OF THE POTENTIAL OF ACETYL COA-CARBOXYLASE AS A NOVEL 
TARGET FOR ANTICOCCIDIAL DRUGS IN BROILER CHICKENS 
 
 
Introduction  
Eimeria spp., the causative agent of coccidiosis in poultry, are apicomplexan intestinal 
parasites ubiquitous in commercial production environments. Intracellular replication of coccidia 
in the host intestinal epithelium results in intestinal damage, nutrient malabsorption, and bacterial 
dysbiosis which predispose the birds to necrotic enteritis (40). There are seven species of 
Eimeria known to infect chickens with varying levels of pathogenicity (154). The three species 
most commonly isolated from commerical broiler facilites are Eimeria acervulina, Eimeria 
maxima and Eimeria tenella. Each species has a tropisim towards specific segments of the 
intestinal track, and several species may infect chickens simultaneously potentially resulting in 
wide-spread intestinal damage (109, 153, 198).  
 Currently, coccidiosis is controlled through inclusion of anticoccidial drugs in feed and/or 
administration of vaccines containing live Eimeria at day of hatch. Anticoccidial drugs have 
been heavily used in commerical poultry production, and although drug rotation has been used to 
reduce and/or delay the development of resistance, reduced drug sensitivity and drug resistant 
Eimiera have been observed in the field (19, 30, 153, 174). There are very few anticoccidal drugs 
commerically available which can be rotated to manage the development of drug resistance. 
 Discovery of new anticoccidial compounds would reduce pressure on the current drugs 
and potentially delay development of resistance., Pharmaceutical companies have historically 
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conducted large screens for potential drugs.  However, with reductions in budgets and advances 
in technology, anticoccidial drug discovery has been more consolidated and focused on drug 
targets. Because of the differences in gene conservation between chickens and Eimeria, recent 
research of new anticoccidial drugs has investigated potential targets in biochemical pathways 
(45). Several commercially available anticoccidial drugs currently target biochemical pathways 
in Eimeria spp. including such as the mannitol cycle, hypoxanthine and guanine acquisition, and 
the urea cycle (44, 197, 243). Since Eimeria are obligate intracellular parasites, determining the 
biochemical requirements of these parasite is difficult and research is scare. However, 
biochemical pathways or specific enzymes not conserved between Eimeria and chickens are the 
most promising for investigation as potential drug targets (88, 140). 
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 Acetyl-CoA carboxylase (ACCase) catalyzes the conversion of acetyl-CoA to malonyl-
CoA and is necessary for fatty acid synthesis in the apicoplast associated with host cell 
penetration (63). In related apicomplexan parasites including Toxoplasma, Plasmodium, and 
Cryptosporidium, broad-spectrum arylphenoxy carboxylic acids inhibitors of ACCase have been 
demonstrated to be effective in reducing parasite infections in mice and calves (88, 108). 
Analysis using X-ray crystallography has demonstrated derivatives of arylphenoxypropionate, 
aryloxyphenoxyacetate, and aryloxyphenylacetate to target the carboxyltransferase (CT) subunit 
of Mycobacterium tuberculosis ACCase (181). Computational analysis of homology-based 
structural models of the CT domain of Eimeria ACCase suggests these compounds may also 
target orthologous sites in Eimeria (194). Thus, ACCase may be a potentially important target 
for the development of anticoccidial drugs. In this study, we investigate the potential of ACCase 
as a target for the development of anticoccidial drugs. We will evaluate the effect of broad-
spectrum arylphenoxy carboxylic acid inhibitors of apicomplexan ACCase in reducing gross 
intestinal lesions in broiler chickens experimentally infected with Eimeria. 
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Materials and Methods 
 Small molecule compounds predicted to have broad-spectrum inhibitory activity against 
acetyl CoA carboxylase (ACCase) from the arylphenoxy carboxylic acids including 
arylphenoxypropionate, aryloxyphenoxyacetate, and aryloxyphenylacetate, and their derivatives 
were chemically synthesized, purified, and analyzed for purity in the laboratory of Dr. James C. 
Sacchettini (Texas A&M University). Additionally, double amine substituents were also 
synthesized in order to evaluate non-orally absorbed derivatives of the phenoxy ACCase 
inhibitors. Individual candidate compounds were prepared for administration by oral gavage as a 
10% (%w/v) DMSO solution and diluted in order to deliver 20 mg dose in 1 mL of vegetable oil 
suspension. For in-feed administration, candidate compounds were prepared as a pre-mix in 
limestone (1:10) and added to feed at 280 mg kg-1 feed to achieve a cumulative dose of 180 mg 
per experimental animal during the treatment period based on predicted feed consumption from 
the breeder. Compounds were mixed at a 1:10 ratio of commercial limestone. These premixes 
were then added to the respective diets for an inclusion of 20/mg/bird/day. In the study 
evaluating highly and lowly absorbed, the concentrations were decreased to 10/mg/bird/day. In 
order to protect the proprietary structures of these compounds, each candidate compound will be 
designated using a unique single letter code which will remain the same throughout all the 
studies.  
 Male broiler chicks (Cobb) were used in all experiments, housed in coccidia-free battery 
brooders, and provided feed and water ad libtum for the duration of each study. Animal care was 
provided in accordance with protocols approved by the Texas A&M University Institutional 
Animal Care and Use Committee (IACUC). Experimental rations were formulated to meet or 
exceed NRC requirements for broiler chickens (161). When appropriate salinomycin was added 
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to feed according to the manufacturer’s instructions (60 ppm), while ACCase inhibitor/limestone 
compound premixes were added to achieve the desired dose.  
 Broiler chickens were experimentally infected by oral gavage with 106 oocysts using a 
commercial vaccine (Huvepharma, Inc.) containing non-attenuated live oocysts of Eimeria 
acervulina, E. maxima and E. tenella.  
 Two sets of birds were used: those orally administered the novel compound at inclusion 
rate of 20 mg/kg bird and those administered 40 mg/kg bird. Another group of birds were given 
the compound in the feed, and then infected with Eimeria (100,000 oocysts) to determine if 
infection altered absorption. 300 uL of blood was taken from 3 birds/time point/drug inclusion 
level in the first study and from 5 birds/time point/Eimeria infection in the second study. 
 Collected whole blood samples were collected, inverted. and stored on ice prior to 
separation of plasma using centrifugation. 20 uL of plasma was removed and added with 2.5 uL 
Internal Standard solution of methanol and Warfarin (1 ug/mL), 500 uL of methanol and 0.1% 
Formic acid. The solution was centrifuged at 14,000 rpm for 5 minutes (194). This was repeated 
and the supernatant was removed and pellet dried in speed vacuum at 40 C (194). Samples were 
reconstituted in 100 µL of acidified methanol, transferred into clean vial inserts, and 10 µl were 
subjected to LC-MS analysis (194). 
 A 10 µL sample solution was injected into a Kinetex 2.6 um EVO C18 100A LC Column 
100 x 4.6 mm and separated by a mobile phase gradient elution of acetonitrile (A) and water (B) 
both containing 0.1% formic acid at a flow rate of 0.5 mL/min. An Agilent 1200 Series LC 
system was used to start acetonitrile at 10% and increase linearly to 100% from 0 to 8 minutes, 
hold B at 100% from 8 – 12 minutes, decrease linearly from 100% to 10% from 12 – 14 minutes, 
and hold at 10% for an additional 3 minutes (total 17 minutes). A Bruker Daltonics micrOTOF-Q 
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II LC/MS with an electrospray ionization system was operated in positive mode, at a source 
temperature of 2200 C, dry nitrogen gas flow of 11 L/min, and under 3.5 bar of pressure. A 0.4 
mg/mL sodium formate external calibration solution was directly injected at 13.0 minutes for 
future data processing and calibration. Quantitation was based on integrating peak area 
corresponding to the elution of internal standard and target compound in the extracted product 
ion chromatograms. 
 Standard calibration curves for each compound were prepared in acidified methanol in 
concentrations ranging from 1.95 to 1000 ng/mL using Warfarin (25 ng/mL as an internal 
standard. A series of 10 calibration standards and in vivo samples were assayed together along 
with 4 quality control samples. Data was collected using Bruker Hystar Software 4.1 and 
extracted ion chromatograms were created for each compound and Warfarin. Standard curves 
were constructed by plotting drug/internal chromatographic peak area ratio against the known 
drug concentration in each calibration standard. Calibration curves were fitted in a cubic curve 
with the y-intercept forced to zero. 
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 Broiler chicks were placed on untreated feed and water and allow to acclimate for 10 
days upon arrival to research facilities. On Day 10, birds were weighed, wing-banded, randomly 
assigned to treatment pens with similar starting weights, and provided their respective treatment 
diets. On Day 12, birds were experimentally infected with Eimeria (106 oocysts bird-1) by oral 
gavage, while uninfected control birds were administered a mock infection containing water. On 
Day 18, the studies were terminated and all experimental animals were euthanized. Individual 
body weights were measured on Day 10 and Day 18, and feed consumption was determined on a 
pen basis. Sections of the duodenum, jejunum and cecum were dissected and gross intestinal 
lesion scored were scored using the method of Johnson and Reid (1970)(113). 
 One study, using 20 birds per treatment, was conducted to evaluate oral absorption of 2 
candidate ACCase inhibitors administered by oral-gavage or in-feed. A second study was 
conducted to determine the effect of two orally-administered ACCase inhibitors in reducing 
Eimeria-induced lesions using 20 birds per treatment and two replicate pens. A third study 
evaluating the effect of administering 9 candidate ACCase inhibitors administered in–feed in 
reducing Eimeria-induced lesions was performed using 24 total birds per treatment across 4 
replicate pens. A fourth study comparing the effects of absorbed and non- absorbed ACCase 
inhibitors administered in-feed was conducted using 36 total birds per treatment across 6 
replicate pens.  
 Data was analyzed using one-way ANOVA General Linear Model (GLM). Significantly 
different means were separated using Duncan’s multiple range test with α = 0.05.  
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Results  
Test compound A was used to evaluate the potential intestinal absorption of the phenoxy 
acid derived ACCase inhibitors administered by oral gavage and in-feed during Eimeria 
infection. Plasma concentration of Compound A from three birds per time point was evaluated 
over 24 hours post administration by oral gavage with 20 mg or 40 mg of compound 
administered per bird (Figure 4.1). The total plasma absorption of Compound A, represented 
using the area under curve (AUC)for was 4.685 and 5.270 ug hr mL-1 for birds receiving a 20 mg 
and 40 mg dose respectively. While the maximum plasma concentration (Cmax ) was 0.794 
µg/mL and 1.013 µg/mL for birds receiving the 20 mg and 40 mg doses, respectively. Thus, 
increasing the dose from 20 mg to 40 mg resulted in a 20% increase in total absorption and a 
25% increase in maximum plasma concentration for Compound A. Additionally, no mortality or 
clinical symptoms of toxicity were observed in any of the birds.  
The potential effects of infection by mixed Eimeria spp. on drug absorption was 
evaluated (Figure 4.2). Compound A was administered in feed at a dose of 280 mg/kg feed to 
infected and uninfected broilers and plasma concentration was evaluated at 2.5 and 5.0 hours 
post administration. No difference in average plasma concentration between infected and 
uninfected broilers was observed at 2.5 hr post administration, but plasma concentrations of 
infected broilers was significantly lower than that of uninfected broilers at 5 hr post 
administration (Figure 4.2A).  Additionally, because feed consumption varies and individual 
feed consumption was not recorded, drug absorption of individual birds was also evaluated 
(Figure 4.2B). Plasma concentrations of the drug were variable across individuals for both 
uninfected and infected birds. The plasma concentration of one uninfected bird was almost 
double the concentration of the other four uninfected birds the at 5 hours post drug 
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administration. Overall, plasma concentration was generally lower in the infected birds as 
compared to the  uninfected birds. While plasma concentrations were higher at 5 hours post drug 
administration in the uninfected birds, plasma concentrations were higher or equal in only 3 of 
the 5 infected birds.  
A preliminary evaluation of the effect of AACase inhibitor administration using oral-
gavage on Eimeria infection in broiler chickens was performed (Figure 4.3). The efficacy of 
both ACCase inhibitors in reducing coccidiosis lesions was variable across each segment of the 
intestine of experimentally infected broiler chickens (Figure 4.3). Compound B  significantly 
reduced  Eimeria lesion scores in the duodenum (P<0.001) as compared to unmedicated broilers 
(infected control) but did not reduce lesion scores in the jejunum or cecum (Figure 4.3). 
Although Compound A was not observed to a significantly reduce Eimeria lesions in any 
segment of the intestine, lesion scores were numerically lower in the ceca and duodenum as 
compared to the infected control (Figure 4.3). Salinomycin, was observed to significantly reduce 
Eimeria lesions in the duodenum (P<0.001) and ceca (P<0.001) (Figure 4.3). However, Eimeria 
lesion scores in the jejunum were higher for broilers administered salinomycin that for the 
infected controls (P=0.009) (Figure 4.3).   
 BWG was significantly greater when broilers were administered salinomycin  greater 
(P<0.001) when compared to the other treatments (Figure 4.4), and no differences in BWG were 
observed between the other treatments  (Figure 4.4).   
 The effect of in feed administration of 9 novel ACCase inhibitors in reducing coccidiosis 
lesion scores was evaluated in experimentally infected broilers (Figure 4.5). Administration of 
the various phenoxy ACCase inhibitors had a significant effect on the development of Eimeria 
lesion scores in the duodenum (P = 0.007), jejunum (P = 0.003), and the cecum (P < 0.001), with 
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the individual compounds having varying efficacy in reducing Eimeria lesions in each segment 
of the intestinal tract of broiler chickens.  
In the duodenum (Figure 4.5A), lesion scores of broilers administered the phenoxy 
ACCase inhibitors were lower than the unmedicated infected control (UIC) or at least similar to 
the Salinomycin treated broilers. Although administration of Compounds D and F was not 
observed to significantly reduce lesion scores when compared the control infection, lesion scores 
were similar to the Salinomycin treated broilers. Administration of the remaining compounds 
was observed to significantly reduce lesions scores when compared to the control infection. In 
the jejunum (Figure 4.6B), administration of salinomycin did not reduce lesions when compared 
to the control infection. However, lesions scores in the jejunum were significantly reduced 
compared to the control infection when broilers were administered compounds D,E, F, G and I 
(Figure 4.5B). In the cecum (Figure 4.5C), E. tenella lesion scores were lower than the control 
infection only for broilers administered Compound B and Salinomycin.  
Body weight gain of experimentally infected broilers was significantly lower than for the 
uninfected control broilers regardless of the treatment administered. However, Salinomycin was 
the only treatment to significantly increase the body weight gain when compared to the 
Untreated-Infected Control broilers (Figure 4.6). Salinomycin was also the only treatment to 
improve FCR compared to the UIC (Figure 4.6).  
The effect of the administration of double amine substituents was evaluated in order to 
determine whether intestinal absorption of phenoxy ACCase inhibitors was required to reduce 
the effects of Eimeria infection in broiler chickens. No significant differences were observed in 
E. acervulina lesions, including the unmedicated control (P=0.082) (Figure 4.7A). However, 
there was a trend observed that salinomycin was lower than Compound K, a low-soluble 
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ACCase inhibitor. No differences were observed with E. maxima lesions in the jejunum, 
including the unmedicated control (Figure 4.7B) (P=0.938). Salinomycin, highly absorbed 
Compound B and low-absorbed Compound K significantly reduced E. tenella lesion scores in 
the ceca compared to the infected control (Figure 4.7C) (P<0.001). No significant differences 
were observed between the unmedicated control and low-absorbed Compound J.  
 A significant effect of coccidia infection was observed on BWG from D10-D18 (Figure 
4.8A) (P<0.001). Salinomycin bird weights were significantly different from the uninfected and 
the unmedicated control (Figure 4.8A) (P<0.001). Compound J and K were not different from 
the unmedicated control (Figure 4.8A). Compound B was significantly lighter than the 
unmedicated controls (Figure 4.8A) (P<0.001). A significant effect of coccidia infection was 
observed in FCR D10-19 (Figure 4.8B) (P<0.001). The uninfected controls had significantly 
lower FCR than all treatments D10-18 (Figure 4.8B). No significant differences in FCR D10-18 
were observed between salinomycin and the unmedicated control (Figure 4.8B). Compound B 
FCR D10-18 was significantly higher than the unmedicated control (Figure 4.8B) (P<0.001).  
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Discussion    
 Apicomplexan parasites are distinguished by the presence of an apicoplast, an organelle 
thought to have arisen from endosymbiosis of an algal cell which had incorporated a 
cyanobacterium (141).  Enzymes in pathways expressed in the apicoplast may serve as  
promising drug targets because  they are  not conserved in the cells of these parasites’ hosts  
(87). Additionally, because of the apicoplast’s likely plant origin, herbicides and their derivatives 
have been shown to be efficacious drugs against some Apicomplexan parasites.  
 Arylphenoxy acid derivatives have been used widely as herbicides for the control of 
some broadleaf plants in crop production (89).  The “phenoxy” herbicides inhibit Acetyl CoA-
Carboxylase (ACCase) localized in the chloroplasts of Graminaceae plants (95). The 
insensitivity of ACCases of other plants, mice, and humans to the phenoxy herbicides allows 
their wide-spread commercial application (200). ACCase catalyzes the conversion of acetyl-CoA 
to malonyl-CoA which is the first committed step of fatty acid synthesis. Because it is necessary 
for fatty acid synthesis in the apicoplast and is associated with host cell penetration, ACCase is a  
potentially important target for the development of therapeutic drugs against apicoplast parasites 
(227).These drugs have been shown to target the carboxyltransferase (CT) domain of 
apicoplastic ACCase, but have no effect on the cytosolic form of the enzyme (88). In vitro 
studies with Apicomplexan Toxoplasma gondii, administration of a selected ACCase resulted in 
70% inhibition of parasite growth (263). Importantly, phenoxy acids are produced inexpensively. 
In 2005, the estimated price of one gram of clodinafop, an effective inhibitor of T. gondii, was 
less than 15 cents (87). Commercial production of these drugs to the scale useful for the poultry 
industry, could prove affordable for poultry producers.  
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Compound A was administered to broiler chickens by oral gavage (Figure 4.2) and in-
feed (Figure 4.2) in order to model intestinal absorption of phenoxy acid derivative ACCase 
inhibitors. We have demonstrated that Compound A was absorbed intestinally when 
administered in-feed or as a bolus by oral gavage, suggesting that other phenoxy acid derivatives 
would also likely be absorbed intestinally. Pharmacokinetic data has demonstrated high intestinal 
absorption of most all commercially available anticoccidials such as Amprolium and 
Salinomycin (17, 92, 98, 124, 165, 175). However, decoquinate is the only commercially 
available anticoccidial in the United States that has low-absorption rates (50). Absorption of 
Compound A was comparable to commercially available anticoccidials.   
 Additionally, oral absorption of Compound A was compared between Eimeria infected 
and uninfected birds. Absorption of Compound A was higher in uninfected birds compared to 
Eimeria infected birds. Individual drug serum levels were variable in both Eimeria infected and 
uninfected birds. The absorption of Compound A in Eimeria infected birds was lower than 
uninfected cohorts at 5 hours post feed administration. This may be related to decreased 
absorption of nutrients common to Eimeria infections (116, 201). On the other hand, decreased 
feed intake is often associated with Eimeria infection, which subsequently would reduce in-feed 
drug ingestion (183). However, some research has shown that reduced feed intake results in 
increased drug absorption because of gastric emptying (155). Total absorption (AUC values) of 
the chemical anticoccidial Amprolium has been demonstrated to be greater when birds were 
fasted compared with those under non-fasting conditions (92). 
 Lesion scores for all regions of the intestine were numerically lower when broilers were 
administered ACCase inhibitor compounds when compared to unmedicated controls in the study 
where birds were given ACCase inhibitors through oral gavage. However, except for E. 
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acervulina lesions when compound B was administered, none of the reductions were significant. 
Greater numbers of E. acervulina oocysts are included in the coccidia vaccine used compared to 
E. maxima and E. tenella, so this could explain why there were more differences in lesions 
observed between treatments (Kimminau, unpublished data). No differences in growth 
performance were observed between either ACCase inhibitor and the infected controls. We 
hypothesize that the daily oral gavaging of birds contributed to the performance differences, as 
Salinomycin was administered in the feed. This experiment was designed as a preliminary 
evaluation of the anticoccidial properties of these compounds, and the subsequent experiments 
included more replicates, more birds. and administration of the drugs in- feed.  
 We determined the mixability into feed/water and stability at room temperature of 
phenoxy herbicide derivatives was sufficient for their application in feed (not shown). The 
importance of these characteristics for anticoccidial drugs was outlined by Edgar in 1970 (64).  
Because anticoccidials are more commonly administered in-feed, this is the drug delivery 
method we chose for all subsequent experiments  (154). Although drug premix formulas (Type A 
medicated article) are proprietary, anticoccidials are typically formulated as a mixture containing  
limestone, mineral oil, calcium silicate, silicon dioxide and micro-tracers (119, 237). From the 
results of the pharmacokinetics studies, we can conclude that our compounds were able to be 
absorbed when administered to the bird diets.  
 We conducted an initial evaluation of 9 candidate phenoxy acid derivative ACCase 
inhibitors administered in feed to experimentally infected broilers. The uninfected controls were 
significantly heavier than infected controls, demonstrating a heavy coccidial challenge.   
 Only one of the compounds other than Salinomycin reduced E. tenella lesions, while 
several of the compounds reduced E. acervulina lesions. Anticoccidials have variable 
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anticoccidial efficacy against different Eimeria species. For example, Amprolium is highly 
efficacious against E. tenella and E. necatrix, but is less efficacious against species such as E. 
maxima and E. acervulina (57). Although E. acervulina is not considered highly pathogenic, it is 
commonly found in most commercial broiler production facilities and is known for high 
reproductive potentials (106, 138, 248). Therefore, the compounds with efficacy against E. 
acervulina would be beneficial for commercial broiler production.  
 Because the E. maxima gross lesion scores for were low (0.5 average) in the infected 
control group, it is difficult to interpret anticoccidial efficacy against this species. Single species 
infections would give more insight to efficacy against E. maxima without the E. acervulina-
crowding that is likely the case in this study (248).  
 In this study, the inclusion of the phenoxy compounds (140 mg/kg feed) was more than 
double for Salinomycin (60 mg/kg feed). The extreme drug dose, could explain no significant 
body weight gain in the phenoxy compound treatments. High levels of Salinomycin has been 
shown to reduce body weight of birds (94). Many attribute the continued success of current 
anticoccidials to their ability to allow “leakage” of some coccidia, which reduces the genetic 
pressure for resistance as well as allows immunity development (32). Determining the dose of 
the ACCase inhibitors that sufficiently reduces coccidia while allowing some leakage to 
stimulate for immune development is important to the potential development of these compounds 
as drugs.   
 Another reason for the lack in performance differences is the activity of the compounds 
against specific Eimeria. Some Eimeria, such as E. maxima, require fewer oocysts to reduce 
performance (42). Others such as E. tenella, are pathogenic, but require more oocysts to reduce 
performance (42). Some of the novel compounds that demonstrated reduction of E. tenella 
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lesions, may not necessarily improve performance comparable to the UUC treatment. Future 
research with single species infections would allow better comparison of anticoccidial activity 
for each Eimeria species.  
 These experiments were designed to evaluate the ability of ACCase inhibitors to reduce 
coccidiosis lesions. The Eimeria challenge was strong, and in one of our studies, caused 
mortality. However, the study did not account for compensatory gain that is seen after Eimeria 
infection (250). Lowering the dose of drug as well as extending the time period of the study 
would allow for better understanding of the ACCase inhibitors ability to reduce coccidiosis 
lesions as well as improve performance when compared to the control infection treatment.    
 Salinomycin did not reduce E. maxima lesions but was higher than the unmedicated 
controls in all of the in-vivo studies. Previous research with mixed Eimeria infections showed E. 
maxima lesions were not significantly different with inclusions of Salinomycin (66 ppm) or 
unmedicated controls (41). Research with single E. maxima infections and Salinomycin (66 ppm) 
demonstrated a reduction in lesion scores, but was not as efficacious as semduramicin (325 ppm) 
(43). Because the Eimeria isolates used were from a coccidia vaccine, which are sensitive to 
anticoccidials, so resistance is not likely. However, research has shown co-infection with E. 
acervulina can interfere with reproductive potentials of E. maxima, E. brunetti, E. necatrix and 
E. tenella infections (248). Salinomycin is very effective at reducing E. acervulina (61, 260). It 
may be possible that the E. acervulina from the vaccine was reduced enough by Salinomycin, to 
give vaccine E. maxima more opportunity to infect.  
 Anticoccidials have a varying level of intestinal absorption. Some such as Amprolium, 
Salinomycin and Toltazuril are highly absorbed while others such as decoquinate are not (50, 
71). A benefit of lowly absorbed drugs is that they have lower toxicity. Researchers administered 
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nequinate, a quinolone related to decoquinate, at 100 times the therapeutic level with no adverse 
effects of the birds (193).  For example, Decoquinate is not absorbed, with 97.5-99% recovery of 
after oral administration (50, 71).  Others such as Salinomycin are more bioavailable and readily 
absorbed (17). 
 In our study, it did not appear that the lower-absorbed drugs were more efficacious in 
reducing lesion scores. Although not significant, the body weights of the birds with the higher 
absorbed drug (Compound B), were lower than the lower-absorbed drugs.  
 In an earlier study, Compound B significantly reduced lesions for E. acervulina and E. 
tenella but not E. maxima. The inclusion levels of the drug in that study were 280 mg/kg feed, 
and 140 mg/kg feed in this study. Since there was no significant reduction in the lesions when a 
lower level of drug was included, a dose response study would give more insight to an optimum 
amount.  
 Research in plants with these ACCase inhibitor herbicides has shown that variation in 
residues where the herbicide binds, may account for variable sensitivity (87). Therefore, it seems 
plausible that modifying these dimer binding sites to target Apicomplexa specific residues, could 
drastically improve the efficacy of these inhibitors against specific parasites such as Eimeria. It 
seems ACCase is a promising drug target and these inhibitors warrant further research as 
anticoccidials.   
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Figure 4.1: Pharmacokinetics of Orally Gavaged Compound A. Drug given at 20 mg/kg bird 
and 40 mg/kg bird. 
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Figure 4.2: Drug Plasma Concentration. A-Top:. Average drug plasma concentrations in 
Eimeria infected (Inf) or uninfected (Uninf) birds 2.5 or 5 hours after given feed with 280 mg 
compound A /kg feed. B-Bottom: Individual plasma drug concentrations of Compound A in 
Eimeria infected or uninfected birds 2.5 or 5 hours after given feed with 280 mg compound /kg 
feed. 
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Figure 4.3: Lesion Scores. (A) Gross intestinal lesions in the (A) duodenum caused by E. 
acervulina, (B) jejunum caused by E. maxima and, (C) cecum caused by E. tenella.  Lesion 
scores expressed as the mean ± SEM from 20 broilers per treatment. Different letters indicate 
means are significantly different (P < 0.05). UNM is unmedicated, infected control. SAL is 
Salinomycin. 366 and 369 are two compounds used.   
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Figure 4.4: Body Weight Gain (10 – 18D). BWG expressed as mean ± SEM from 20 broilers 
per treatment. Different letters indicate significantly different means (P < 0.05). UNM is 
unmedicated, infected control. SAL is Salinomycin. 366 and 369 are two compounds used.   
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Figure 4.5: Lesion Scores. Gross intestinal lesions in the (A) duodenum caused by E. 
acervulina (B) jejunum caused by E. maxima and, (C) cecum caused by E. tenella.; UIC, 
untreated infected control; SAL, salinomycin. Lesion scores expressed as the mean ± SEM from 
4 pens per treatment. Different letters indicate significantly different means (P < 0.05). UUC is 
unmedicated, uninfected control. UIC is unmedicated, infected control. S is Salinomycin. A, B, 
C, D, E, F, G, H and Iare respective compounds used.  
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Figure 4.6: Broiler Performance Results. (A) Body weight gain D10 –D18. (B) Average Pen 
FCR D10-D18. UU, untreated uninfected control; UI, untreated infected control; S, salinomycin. 
Both expressed as mean ± SEM from 4 pens per treatment. Different letters indicate significantly 
different means (P <0.05). UUC is unmedicated, uninfected control. UIC is unmedicated, 
infected control. S is Salinomycin. A, B, C, D, E, F, G, H and I are respective compounds used.  
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Figure 4.7: Lesion Scores. Gross intestinal lesions in the (A) duodenum caused by E. 
acervulina, (B) jejunum caused by E. maxima and, (C) cecum caused by E. tenella. Lesion 
scores expressed as the mean ± SEM from 4 pens of 6 broilers per treatment. Different letters 
indicate significantly different means (P < 0.05). UUC is unmedicated, uninfected control. UIC 
is unmedicated, infected control. SAL is Salinomycin. B, J and K are respective compounds 
used.  
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Figure 4.8: Broiler Performance Results. Average individual body weight gain D10-D18. 
BWG expressed as mean ± SEM from 36 broilers per treatment. Different letters indicate 
significantly different means as determined using Duncan’s multiple range test (P < 0.05).UUC 
is unmedicated, uninfected control. UIC is unmedicated, infected control. SAL is Salinomycin. 
B,J and K are respective compounds used.  
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CHAPTER V 
CONCLUSION 
 
 
 Control of coccidiosis and necrotic enteritis is a significant cost to poultry producers 
world-wide. Because of the ubiquity of C. perfringens and Eimeria in poultry production 
environments, it is unlikely these pathogens will be eradicated. Thus, emphasis must be placed 
on improving current control methods as well as researching new drugs and additives as a part of 
overall management programs to help mitigate intestinal damage.  
 The research presented here investigated antibiotic free, conventional and exploratory 
interventions. The future control of coccidiosis and necrotic enteritis will rely not only on 
optimizing current interventions but development of new ones as well. As more producers move 
from antibiotic-use during poultry production, alternatives will continue to be required. For 
poultry producers that continue to use non-human antibiotics, such as ionophores, understanding 
the dynamics of concurrent use of these products and vaccines is also important.  
 Each intervention evaluated showed variable efficacy in reducing coccidiosis and 
necrotic enteritis. The DFM tested with a coccidia vaccine demonstrated some efficacy in 
reducing vaccine-related performance losses. Future research into other DFM will potentially 
find products with greater efficacy in reducing performance losses from coccidia vaccine use.  In 
addition, novel ACCase inhibitor compounds showed promising results as anticoccidials. 
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